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Abstract

Human Rifl, the ortholog of the yeast Rapl interacting factor 1, a telomere
length regulator was identified. Immunofluorescence did not reveal an association of
human Rifl with telomeres. Preliminary co-immunoprecipitation with known telomeric
proteins and chromatin immunoprecipitation failed to show an interaction of human Rifl
with telomeric protein complexes or with telomeric DNA. Unexpectedly, Rifl responded
to ionizing radiation (IR), UV light, and clastogens, forming foci that co-localized with
other DNA damage response factors such as 53BP1, ATM, BRCA1, Chkl, Nbsl, and
Rad 17. Furthermore, Rifl localized to uncapped telomeres, as do other DNA damage
response factors. Among DNA damage response proteins, Rifl showed a unique
dependence on the ATM kinase. Whereas inhibition of ATR signaling did not suppress
the Rifl response, ATM deficient cells treated with IR or UV lacked Rifl foci even after
prolonged incubation or high radiation dose. Therefore, IR-induced Rifl foci constitute
an assay for ATM status. The Rifl response also depended on the presence of 53BP1 but
was not affected by reduced function of BRCA1, Chk2, Nbsl, and Mrell. RNAimediated Rifl inhibition resulted in increased radiosensitivity, indicating that Rifl
contributes to ATM-mediated protection against exposure to ionizing radiation.
In order to more fully understand telomere length regulation in mammalian cells
and the evolutionary history of telomere-binding complexes, a search for novel hRapl binding proteins and studies of the Rapl telomere complex at human telomeres were
performed. Both genetic and biochemical methods were used in order to better
understand the role of the Rapl complex, consisting of hRapl, TRF2, and the Mrell

complex, in human telomere biology. A yeast two-hybrid screen was carried out using
hRapl as a bait and two genes were identified. The first gene, called candidate 144
(C144), encodes a novel zinc-finger containing protein. Immunofluorescence and coimmunoprecipitation failed to reveal an association of C144 with telomeres. Deletion of
the open-reading frame YDL175c in S. cerevisiae, the ortholog of C144, did not result in
detectable changes in telomere length. The second gene, called FLASH, was previously
identified to play a role as an adaptor in ligand-mediated apoptosis. In
immunofluorescence experiments, FLASH did not co-localize with known telomeric
proteins.

Introduction

Part 1: The D N A damage response

The viability of both cells and organisms depends on the transmission of genetic

information in an accurate manner. In order to facilitate this process, cells must maintain
genomic stability and prevent an excess of potentially harmful heritable mutations.
Eukaryotes have evolved a variety of checkpoints in order to verify that a proper
sequence of events occurs at each stage of the cell cycle prior to the next. Such events
include replication of genomic DNA once and only once, proper chromsome attachment
to the mitotic spindle, and the presence of necessary growth conditions in the
environment. The classic definition of a checkpoint is a pathway where progress through
the cell cycle can be stopped until conditions are suitable for the cell to proceed to the
next stage (Hartwell and Weinert 1989).
Genomic DNA can be damaged by both endogenous and exogenous stimuli.
Failure to properly repair this damage is catastrophic and can lead to genomic instability
and cell death. A number of specialized checkpoint mechanisms, collectively referred to
as the DNA damage response, have evolved to recognize DNA damage. The ability of
mammalian cells to survive chromosomal damage depends on the coordinated activity of
DNA response pathways that halt cell cycle progression and facilitate DNA repair prior
to DNA replication or mitosis. The DNA damage response extends beyond the classical
definition of the checkpoint pathway because the DNA damage response links cell cycle
arrest mechanisms with diverse processes including the recruitment of protein complexes
to sites of DNA damage, DNA repair, apoptosis and transcription (Zhou and Elledge
2000).

The D N A damage response is a complex and overlapping set of molecular
pathways that detects damage and triggers cellular responses. The ability of cells to
detect double-stranded breaks (DSBs) is exquisitely sensitive and rapid. Studies in which
a single break is generated with the HO endonuclease in yeast indicate that one DSB is
sufficient to generate a DNA damage response and cell death (Weiffenbach and Haber
1981). The detection of DNA damage then initiates the effector arms of the DNA
damage response.
The execution phase of the DNA damage response involves the establishment

and maintenance of cell cycle arrest, repair processes, and the decision to re-enter the ce
cycle or undergo apoptosis. Following the recognition of DNA damage, eukaryotic cells
will halt their cell cycle progression until the DNA damage is repaired. Cells are capable
of undergoing arrest in S and M phases as well as at the Gl/S and G2/M transitions of the
cell cycle through a number of molecular pathways (Figure 1-1). Cells also initiate repair
processes to correct the specific DNA lesion detected (see below). If the DNA damage is
repaired, then cells can re-enter the cell cycle and continue to grow. In certain cases,
such as overwhelming quantities of DNA damage or inability to properly execute repair,
the damaged cell will undergo apoptosis. The exact signals involved in cell-cycle reentry and apoptosis are not currently known.

Nature Reviews | Cancer

Figure 1-1. M e c h a n i s m s of cell cycle arrest in response to double-stranded breaks.
M a n y of the k n o w n factors involved in the D N A d a m a g e response are s h o w n along with
their ability to activate (arrows) or inhibit (t-shaped arrow) one another. Figure taken
directly from Shiloh 2003.

T h e causes and types of D N A damage and repair

DNA can be damaged through a number of mechanisms that each leave signature
alterations in DNA structure. DNA damage can arise from either endogenous or
exogenous means. The three primary ways in which DNA damage occurs are the
exposure of cells to exogenous radiation (including ultraviolet (UV) and ionizing
radiation (IR)) or chemicals (including compounds found in cigarette smoke and cancer
chemotherapy agents), the products of normal cellular metabolism (including reactive
oxygen species and products of lipid peroxidation), and spontaneous chemical changes in
DNA bases (including hydrolysis of nucleotide bases that result in abasic sites and
spontaneous deamination) (reviewed in (Hoeijmakers 2001)). In addition to this list,
normal replication can lead to stalled replication forks which can be processed into
single-stranded and double-stranded DNA breaks. The inability of cells to properly
repair damaged DNA leads to gross chromosome rearrangements (GCRs), a proposed
source of genomic instability (Kolodner et al. 2002). Genes involved in the processes of
maintaining S-phase checkpoints, recombinational repair and telomere maintenance act to
suppress GCR in S. cerevisiae and these genes likely perform similar functions in
mammalian cells (Myung et al. 2001; Kolodner et al. 2002).
Different DNA damage response pathways are capable of detecting and repairing
the various types of DNA damage that occur. These pathways include the mismatch
repair, base-excision repair, transcription-coupled repair, and the repair pathways for

single- and double- stranded breaks. Cells can also replicate directly though certain types
of DNA damage in an error-prone process termed damage tolerance (Friedberg 2003).

The Y-family D N A polymerases are capable of replicating damaged D N A (Goodman
2002). Double-stranded DNA breaks (DSBs) are particularly harmful to the cell because
it is unable to properly progress through mitosis. When DSBs occur as a result of DNA
damage, a rapid DNA damage response begins within minutes in order to facilitate repair
and prevent either replication or mitosis, which would be fatal to the damaged cell
(Khanna and Jackson 2001; van Gent et al. 2001; Jackson 2002).
In mammalian cells, DSBs are repaired with high fidelity by homologous
recombination (HR) or they are processed through the error-prone non-homologous endjoining (NHEJ) pathway. It is unclear exactly how mammalian cells decide whether to
repair DSBs via HR or NHEJ. Since HR is more accurate, it is assumed that this is the
preferred mechanism of DSB repair. However, DSBs that occur in repetitive sequences
should be repaired by NHEJ since HR may lead to inappropriate recombination with an
incorrect locus (Lieber et al. 2003). In S. cerevisiae, DSBs are repaired primarily through
HR (Haber 1995) and loss of NHEJ components do not lead to radiosensitivity in diploid
strains. In vertebrate cells, HR seems to occur preferentially after replication when a
sister is present, whereas NHEJ takes place in Gl (Takata et al. 1998). DSBs also occur
under physiologic conditions including meiotic recombination, V(D)J recombination in
the formation of the T cell receptor and immunoglobulin genes, and isotype class
switching. Factors involved in NHEJ, including Ku70/Ku86, Artemis, DNA-PK,.,,,
XRCC4 and DNA ligase IV, and in HR, including the Mrell complex, Rad51, Rad52,
Rad54, Rad55, Rad57, BRCA1, and BRCA2, play a role in the processing of DNA
breaks.

A T M and A T R : master regulators of the D N A damage response

Ataxia-telangiectasia mutated (ATM) and ATM- and rad3- related (ATR) play a
central role in the response of mammalian cells to IR, UV and replication stress. ATM
was identified in 1995 as the gene mutated in the disease ataxia-telangiectasia (A-T)
(Savitsky et al. 1995). A-T is an autosomal recessive, pleiotropic genetic disorder
characterized by cerebellar degeneration at an early age leading to progressive motor
dysfunction, immunodeficiency, genomic instability, gonadal and thymic atrophy and
cancer predisposition (reviewed in (Shiloh 1995; Lavin and Shiloh 1997; Crawford 1998;
Becker-Catania and Gatti 2001)). The initial observation that A-T patients were
particularly sensitive to the radiotherapy used to treat their lymphoreticular tumors
suggested that A-T was a disorder involving an improper response to DNA damage

(Gotoff et al. 1967; Morgan et al. 1968). At the cellular level, cells from A-T patients are
hypersensitive to IR and other agents that cause DSBs (Agarwal et al. 1977). In response
to IR, these cells have diminished ability to undergo Gl and G2 arrest and reduce their
level of DNA synthesis (Painter and Young 1980; Kastan et al. 1992; Paules et al. 1995).
The ATM cDNA was cloned by two groups and could complement many of the cellular
defects of A-T cells (Zhang et al. 1997; Ziv et al. 1997). Heterozygous carriers of ATM
mutations have an elevated risk of developing breast cancer (Swift et al. 1991; Athma et
al. 1996; Inskip et al. 1999; Olsen et al. 2001). The effect of diminished ATM function
on this finding was recently substantiated in a murine model that also is cancer-prone
(Spring et al. 2002).

A T M and A T R contain a C-terminal domain similar to the protein PI3 kinase
domain. Whereas PI3 kinase phosphorylates lipids, many other members of the PIKK
family, including ATM, ATR, DNA-PK, ATX/SMG-1, mTOR/FRAP, and TRRAP, have
protein targets. DNA-PK plays an accessory role in the NHEJ pathway. TOR proteins
play a role in monitoring nutrient levels and TRRAP, which does not have a functional
kinase domain, plays a role in histone acetylation (Grant et al. 1998; McMahon et al.
1998; Schmelzle and Hall 2000). Members of this family also contain a FAT domain
adjacent to the kinase domain and the exact role of this domain is unclear. PIKK family
members are large proteins with molecular weights ranging from 270 - 450 kilodaltons
and the kinase domain and the FAT domain together make up only a small portion of the
total protein. Members of the PIKK family have been shown to contain numerous HEAT
repeat sequence motifs, which suggests an relationship between PIKKs that extends
beyond the kinase domain (Perry and Kleckner 2003).
ATM and ATR play a central role in the DNA damage response by
phosphorylating target proteins that act as mediators and effectors of the DNA damage
response. ATM has a number of direct targets, including the Nbsl component of the
Mrell complex, a proposed DNA damage sensor that is also involved in recombinational
repair ((Gatei et al. 2000b; Lim et al. 2000; Zhao et al. 2000), reviewed in (Petrini and
Stracker 2003)). Additional ATM targets include Chkl and Chk2, Mdm2, p53 and
53BP1, BRCA1, Rad9, Rad 17, Smcl, and H2AX (reviewed in (Kastan and Lim 2000;
Shiloh 2003)). ATM and ATR, serine/threonine kinases that are often referred to as
(S/T)-Q kinases because the glutamine residue is almost invariably found after either a
serine or threonine residue in phosphorylation sites. A broader consensus sequence was
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identified for A T M by changing the known target sequences and monitoring the effect in
in vitro ATM kinase assays (Kim et al. 1999). A similar approach yielded an optimal
target sequence of LSQE for ATM when a library of peptides was tested (O'Neill et al.
2000).
ATM and ATR phosphorylate overlapping targets. An example of the
overlapping specificity of ATM and ATR is the phosphorylation of p53 on serine 15.
Both ATM and ATR phosphorylate this site both in vitro and in vivo (Banin et al. 1998;
Canman et al. 1998; Lakin et al. 1999; Tibbetts et al. 1999). The phosphorylation of
BRCA1 on residues 1423 and 1524 is another example of a single target that can be
modified by both ATM and ATR (Scully et al. 1997b; Cortez et al. 1999). Even though
ATM and ATR have overlapping target specificities, the kinetics and extent to which
they participate in the phosphorylation of a given target in response to different DNA
damage stimuli often differs. For example, ATM phosphorylates p53 on serine 15 almost
immediately after exposure of cells to IR, whereas ATR phosphorylation of p53 serine 15
occurs only at late stage following IR. Additionally, ATR phosphorylates p53 on serine
15 in a time-independent manner when cells are exposed to UV (Tibbetts et al. 1999).
One basic difference between ATM and ATR signaling is that ATM is more
strongly activated by IR, whereas ATR is more strongly activated by UV and drugs that
cause replication stress such as hydroxyurea (HU). This division is not strict. Targets of
ATM are still phosphorylated in A-T cells in response to IR, albeit with slower kinetics
and to a lesser extent. Furthermore, ectopic expression of ATR can complement the
radioresistant DNA synthesis phenotype in A-T cells (Cliby et al. 1998).

11

T h e detection of double-stranded breaks

The actual detection of DSBs and other DNA lesions is the first step in the
initiation of the DNA damage response. A longstanding question in the DNA damage
field involves the mechanism(s) by which DSBs are detected. It is clear from
immunofluorescence (IF) studies that DNA damage proteins associate with presumptive
sites of DNA damage within minutes (and possibly shorter) after exposure of cells to IR.
A variety of mechanisms have been proposed to explain the rapid and sensitive detection
of DNA damage. It is currently unclear if a single proposed mechanism dominates or if
multiple mechanisms act either simultaneously or in concert. Studies in bacteria and
yeast indicate that lesions such as mismatched bases or abasic sites can be recognized by
specific proteins. Thus, the most obvious mechanism of DSB detection involves one or
more proteins that are able to detect DSBs. Two early candidates as the sensors of DSBs
were poly(ADP-ribose) polymerase (PARP) and DNA-protein kinase (DNA-PK) because
they could recognize abberant DNA structures in vitro. However, genetic evidence has
failed to substantiate these claims and cells deficient in these proteins can still form
ionizing radiation induced foci (IRIF) (Wang et al. 1995; Jimenez et al. 1999). Ionizing
radiation induced foci represent the accumulation of DNA damage response factors on
DNA lesion and these can be visualized with IF microscopy. Thus, these molecules are
either not functioning as sensors or there is considerable redundancy in their function.
ATM and/or ATR have been proposed as direct sensors of DNA damage since
ATM and ATR play a critical role in the cellular response to IR. The question of whether
ATM and ATR can directly recognize DSBs and other abberant DNA structures in vitro
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and in vivo is controversial. Following the generation of D S B s by IR or clastogens,
inactive ATM kinase dimers are converted into active monomers through
autophosphorylation on serine 1981 (Bakkenist and Kastan 2003). This phosphorylation
event takes place at IR doses as low as 0.1 Gy and occurs almost immediately after DNA
damage. The suggested stimulus for this mechanism of ATM activation is a gross change
in chromatin based on the effects of chloroquine and altering salt conditions (Bakkenist
and Kastan 2003). Although the exact mechanism of ATM activation has not been
conclusively established, it is clear that the phosphorylation of ATM at serine 1981 is an
early and critical event in the cellular response to IR. ATR requires a signaling partner,
ATR-interacting protein (ATRIP), in order to respond to DNA damage (Cortez et al.
2001). ATRIP is phosphorylated by ATR and is required for the stability of ATR and
ATR signaling following DNA damage.
Recent studies have provided significant insight into possible mechanisms by
which ATM and ATR could be sensors of DNA damage. A heterotrimeric complex of
Rad9, Rad 1, and Hus 1, often termed the 9-1-1 complex, may act as a sensor. ATM
phosphorylates Rad9 on Serine 272 and Husl is also an ATM target (Chen et al. 2001;
Foray et al. 2003). These proteins are thought to form a structure related to proliferating
cell nuclear antigen (PCNA) (Thelen et al. 1999). Another DNA damage response,
Radl7, is phosphorylated at multiple sites by ATM after IR exposure and is proposed to
have structural homology with replication factor C (RFC) (Green et al. 2000). During
DNA replication, the clamp loader, RFC, loads the heterotrimeric PCNA ring onto the
product of primase and PCNA subsequently facilitates polymerase recruitment and
replication. By analogy, Radl7 may act to recruit and load the 9-1-1 complex onto DSBs
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and other D N A

lesions (Bermudez et al. 2003).

It is unclear whether Rad 17

phosphorylation by ATM is required for this recruitment event. Alternatively, the 9-1-1
complex may act as a surveillance complex to constantly monitor the genome for DSBs
based on its presumptive ability to slide along the DNA.
Finally, another important complex in the DNA damage response, the Mrell
complex, which consists of Mrell, Nbsl and Rad50, acts as a sensor of DNA damage.
The criteria for a DNA sensor are as follows: the sensor should physically associate with
DNA after damage; the sensor should be associated with DNA damage in a manner
independent of activating modifications such as ATM phosphorylation; mutations that
affect the ability of the sensor to bind damaged DNA should correlate with failure to
activate DNA damage cell cycle checkpoints; and it should be possible to identify
mutations that result in a constituitively active damage signal or a sharply up-regulated

signal. Thus far, the Mrel 1 complex fits all of these criteria (Petrini and Stracker 2003).
RPA may also act as a sensor of DNA damage. Recent evidence suggests that RPA
interacts with ATRIP and recruits the ATR-ATRIP complex to ssDNA after DNA
damage (Zou and Elledge 2003). The binding of RPA to damaged DNA in yeast had
previously been demonstrated (Carr 2003).

DNA damage induced cell cycle arrest

The ATM-dependent DNA damage response pathway can affect progression
through the cell cycle before, during, and after DNA replication. ATR also plays a role
in the ability of cells to halt cell cycle progression following DNA damage.
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Cells with D N A damage undergo an arrest at the Gl/S transition that presumably
prevents the cell from replicating damaged DNA until the damage is properly repaired.
The central player in Gl/S arrest of cells after DNA damage is p53, a target of ATM
(Canman et al. 1994; Siliciano et al. 1997; Banin et al. 1998; Canman et al. 1998; Khanna
et al. 1998). p53 functions as a transcriptional activator of the cyclin-dependent kinase
inhibitor (OKI), p21 (el-Deiry et al. 1993; Canman et al. 1994; Dulic et al. 1994; Deng et
al. 1995). p21 directly inhibits the kinase activities of both cylinA-cdk2 and cyclinEcdk2 complexes which facilitate the Gl-S transition. ATM phosphorylates p53 on a
number of residues and it was assumed that this modification is the molecular event that
leads to p53 accumulation and, hence, p21 transcriptional activation. Initial attention
went to p53 serine 15 modification because this residue is in the region of p53 that binds
its inhibitor MDM2. The release of MDM2 from p53 as a result of serine 15
phosphorylation would lead to p53 accumulation. The actual situation, however, is more
complicated. First, serine 15 modification does not affect the p53-MDM2 interaction
(Dumaz and Meek 1999). Second, ATM also phosphorylates MDM2 on residue serine
395 and there is evidence to suggest that this event results in the disruption of the p53MDM2 complex (Maya et al. 2001). Finally, another ATM target, Chk2, is itself a kinase
and phosphorylates p53 on serine 20 (Chehab et al. 2000; Hirao et al. 2000; Shieh et al.
2000). Serine 20 phosphorylation interferes with the p53-MDM2 interaction. In
addition to the various mechanisms by which p53 accumulates after DNA damage, Gl
arrest to DNA damage is more complicated than p53 transcriptional activation of p21.
More specifically, Gl arrest following DNA damage is at least a two-step process with an
initial p53-independent process mediated by cyclin Dl proteolysis followed by a slower
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arrest maintenance mediated by p53-dependent p21 transcription (Agami and Bernards
2000).
Cells also activate an intra S-phase checkpoint following DNA damage
presumably in order to resolve stalled replication forks. A number of redundant
molecular mechanisms underlie the intra S-phase checkpoint. The phenomenon of
radioresistant DNA synthesis (RDS), which is the inappropriate replication of DNA
following DNA damage, was first observed in A-T cells (Painter and Young 1980).
ATM phosphorylates Chk2, which has a role in Gl/S arrest but also plays a role in the
intra S-phase checkpoint. ATM and Chk2 are responsible for the phosphorylation of
Cdc25A, resulting in its degradation (Falck et al. 2001). The destruction of Cdc25A
prevents the dephosphorylation of Cdk2 which leads to intra S-phase arrest. Cdk2 is
necessary for DNA replication because it loads Cdc45, which recruits the MCM complex
to cellular origins of replication (Walter and Newport 2000). The intra S-phase
checkpoint is due in part to phosphorylation of Nbsl, Smcl, FANCD2, and BRCA1 by
ATM (reviewed in (Shiloh 2003)). The phosphorylation of Nbsl and Chk2 by ATM act
as separate and parallel pathways in the intra S-phase checkpoint (Falck et al. 2002).
Finally, cells with DNA damage undergo an arrest at the G2/M transition,
presumably to prevent the cells from undergoing mitosis and segregating defective or
broken chromosomes. Similar to the other checkpoint responses to DNA damage, the
G2/M arrest following damage results from an overlapping series of mechanisms. Both
ATM and ATR play a role in the G2 arrest pathway through their phosphorylation of
Chkl and Chk2, respectively. Chkl and Chk2 subsequently phosphorylate Cdc25C,
which leads to the dephosphorylation of Cdkl (reviewed in (Shiloh 2003)). It has been
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proposed that phosphorylated Cdc25C binds 14-3-3 proteins which render Cdc25C
inactive and unable to activate the mitotic cyclin B/Cdc2 kinase (Abraham 2001).

The DNA damage response signal transduction network

The DNA damage response is often described as a signal transduction network
with one or more DNA damage signals detected by sensors which signal to effectors
through a series of mediators and transducers. Signal amplification is a common property
of transduction pathways. The phosphorylation cascade that results from ATM and ATR
activation described above acts to modify and mobilize multiple cellular proteins in
response to even a single DSB. Redundancy and cross-talk are two additional hallmarks
of signal transduction which apply to the DNA damage response. The redundancy and
cross-talk of ATM and ATR have been described above. Redundancy and cross-talk
complicate the study of the DNA damage response just as they complicate the study of
other signaling networks.
An appreciation of the complexities of the DNA damage response provides a
more realistic picture of what occurs in the cell following DNA damage. First, there is
not always a sharp distinction between DNA damage sensor, transducer and effector. As
discussed above, many of the proposed sensors also serve as transducers and effectors in
response to DNA damage. Also, many proteins play a number of distinct roles in the
DNA damage response. Several DNA damage response factors such as 53BP1, BRCA1,
and the Mrell complex have multiple toles in the DNA damage response. Additionally,
traditional notions of upstream and downstream signaling relationships are not always
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instructive and m a y be difficult to dissect in the rapid D N A damage response.

As

discussed below, the Mrell complex appears to function both upstream and downstream
of ATM. Finally, the effector functions of the DNA damage response occur
simultaneously and involve common players. It is likely that the cell monitors the
consequences of both cell-cycle arrest and repair in order to determine whether damage
can be resolved or apoptosis should be initiated.
The following sections will feature a description of a number of key players in
the mammalian DNA damage response. Their roles in various aspects of the DNA
damage response, such as checkpoint arrest, phosphorylation, and repair will be
discussed.

53BP1

53BP1 was originally identified as a protein that interacts through a yeast twohybrid screen with p53 and was subsequently shown to be a co-activator of p53dependent transcription (Iwabuchi et al. 1994; Iwabuchi et al. 1998). 53BP1 contains
BRCA1 carboxy terminal (BRCT) domains that are often found in DNA damage
response factors and, as a result, the hypothesis arose that 53BP1 functions in the DNA
damage response. Indeed, both human and Xenopus 53BP1 formed IRIF rapidly which
co-localized with other known DNA damage response proteins (Schultz et al. 2000;
Anderson et al. 2001; Rappold et al. 2001). Although the exact details differed slightly in
the original publications, it appears that 53BP1 responds more strongly to IR than to UV
or replication stress; that 53BP1 is phosphorylated in vitro and in vivo by ATM; and that,
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although 53BP1 is capable of forming IRIF in A-T cells, the kinetics and extent of IRIF
formation depend on ATM (Schultz et al. 2000; Anderson et al. 2001). Numerous studies
have attempted to elucidate the specific function of 53BP1 in the DNA damage response.
53BP1 is found at the kinetochore during mitosis and it is suggested that this may play a
role in the mitotic checkpoint (Jullien et al. 2002). An siRNA approach that lowered
levels of 53BP1 revealed that 53BP1 plays a role in p53 accumulation, the G2/M
checkpoint, and the intra-S-phase checkpoint in response to IR (Wang et al. 2002).
53BP1 forms foci in cancer cell lines expressing mutant p53, which suggests that the
DNA damage respsonse may be constuitively activated in human tumors lacking p53
(DiTullio et al. 2002). The exact role of 53BP1 in DNA damage response signal
transduction is still under investigation.

BRCA1

Breast cancer 1 (BRCA1) plays an assortment of roles in the DNA damage
response. Germline mutations of BRCA1 lead to a hereditary breast and ovarian cancer
syndrome (Miki et al. 1994). BRCA1 is a large molecular weight protein that contains an
N-terminal RING domain and two C-terminal BRCT domains (Wu et al. 1996; Bork et
al. 1997; Callebaut and Mornon 1997). A large number of proteins with BRCT domains
play a role in the DNA damage response and several factors, including TopBPl, MDC1
and 53BP1, have been identified as DNA damage response proteins because of the
presence of one or more BRCT domains (Makiniemi et al. 2001; Yamane et al. 2002;
Goldberg et al. 2003; Lou et al. 2003a; Lou et al. 2003b; Stewart et al. 2003; Xu and
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Stern 2003). B R C A 1 has many characterized cellular functions and it is difficult to
identify which functions are critical for the DNA damage response. Early studies reveal
that BRCA1 can function as a transcription factor with association to RNA pol II via
RNA helicase A and that it can function in a complex with histone deacetylase activity
(Scully et al. 1997a; Anderson et al. 1998; Yarden and Brody 1999). BRCA1 has a large
number of proposed interacting partners, including BARD1 and CtlP. BRCA1 was
shown to interact with the Mrell complex and biochemical purification revealed a large
molecular complex termed the BRCA1 genome surveillance complex (BASC) which
contains a variety of DNA damage components (Zhong et al. 1999; Wang et al. 2000).
A large body of experimental evidence suggests that BRCA1 plays a role in the
cellular response to DNA damage. BRCA1 forms nuclear foci during S phase and when
exposed to DNA damaging stimuli such as UV, IR or mitomycin C (Scully et al. 1997b).
A cell line termed HCC1937, deficient in BRCA1, was shown to be hypersensitive to IR
(Scully et al. 1999). BRCA1 is a target of ATM and co-immunoprecipitates with ATM
(Cortez et al. 1999). BRCA1 is directly phosphorylated by ATM on a number of
residues, including serine residues 1387, 1423, 1457 and 1524 as shown by phosphospecific antibodies (Gatei et al. 2000a; Gatei et al. 2001). The ATM-dependent BRCA1
phosphorylation on serine 1387 is necessary for the ATM-mediated intra-S-phase
checkpoint (Xu et al. 2002b). ATR can also phosphorylate BRCA1 (Tibbetts et al. 2000).
BRCA1 is required for a subset of ATM- and ATR- dependent responses to DNA
damage (Foray et al. 2003). Chk2 phosphorylates BRCA1 at serine 988 and this event is
important for rescue of cell survival after damage in HCC1937 cells (Lee et al. 2000).
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The exact mechanism by which B R C A 1 deficiency leads to tissue-specific
tumorigenesis is currently unknown. One possibility is the concept of redundancy in
which tissues other than the breast and ovary are able to properly execute BRCAl's
functions in its absence. Conversely, it has been suggested that only breast and ovary
provide a suitable environment for cells that have lost BRCA1 to survive. This idea is
termed the BRCA1 suppressor hypothesis (Elledge and Amon 2002). The finding that
BRCA1 co-localizes with the inactive X chromosome in females provides another
possible mechanism underlying tissue-specific tumorigenesis upon loss of BRCA1
(Ganesan et al. 2002). The authors propose that perturbations of the behavior of the
inactive X resulting from BRCA1 loss may contriute to tumorigenesis in the breast and
ovary.

The Mrell complex

The Mre 11 complex is a large molecular-weight complex consisting of Mre 11,
Nbsl (originally termed p95), and Rad50 that plays a role in the DNA damage response
as well as a diverse array of other biological activities. Mrell complex components are
evolutionarily related to the SbcCD proteins found in bacteriophage T4, bacteria, yeast,
Drosophila, and vertebrates (Sharpies and Leach 1995). The Mrell complex has a
structure resembling SMC proteins and have a 3' -> 5' nuclease activity in vitro
(Sharpies and Leach 1995; Connelly et al. 1999). The Mrell complex in yeast,
consisting of Mrell, the Nbsl ortholog Xrs2, and Rad50 has been extensively
characterized. It is known to play a critical role in the following three biological
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processes: the creation of meiotic D S B s through the removal of Spoil, homologous
recombination, and the DNA damage response (reviewed in (Haber 1998; Petrini and
Stracker 2003)). The identification of a human ortholog of Mrel 1 began the study of the
human Mrell complex and human orthologs of Rad50 and Nbsl were subsequently
identified (Petrini et al. 1995; Dolganov et al. 1996; Carney et al. 1998). The Mrell
complex is essential in chicken and mouse cells, but it is unclear which function is
responsible for this property.
The known biochemical functions and interaction partners of the Mrel 1 complex
may contribute to its biological function(s). Nbsl has a 3' to 5' exonuclease activity in
vitro (Trujillo et al. 1998). It has been suggested that this nuclease activity may work on
DSBs and facilitate repair (Paull and Gellert 1998), although the exact mechanism is
unknown. The Mrell complex has a helicase activity as well which is potentiated by
Nbsl (Paull and Gellert 1999). A proposed zinc hook structure for Rad50 suggests that
it might bridge multiple DNA molecules together and this may enable the Mrell
complex to properly carry out its roles in DSB repair and recombination (Hopfner et al.
2002). The Mrel 1 complex has been shown to co-immunoprecipitate with mediator of
DNA damage checkpoint 1 (MDC1), an important DNA damage response factor (Stewart
et al. 2003). Mrel 1 complex has also been found at human telomeres as part of the TRF2
complex (Zhu et al. 2000).
The components of the Mrel 1 complex play an important role in the reponse to
DNA damage. Mrel 1 complex components were among the first proteins shown to form
IRIF in response to DSBs (Maser et al. 1997). A special overlay technique using a
layered grid placed over cells exposed to soft x-rays provides evidence that these IRIF
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correspond to sites of D S B s (Nelms et al. 1998). Mrell complex components were
originally predicted targets of ATM phosphorylation (Kim et al. 1999). It was then
subsequently shown that Mrell and Nbsl are targets of ATM. Nbsl is necessary for
Mrel 1 phosphorylation after damage (Dong et al. 1999). ATM phosphorylates Nbsl and

loss of this site leads to a defect in the intra-S-phase checkpoint (Gatei et al. 2000b; Li
et al. 2000; Zhao et al. 2000). The Mrell complex also plays a role in the G2/M
checkpoint following IR (Xu et al. 2002a). Nbsl is required for Chkl phosphorylation
after IR (Gatei et al. 2003). Interestingly, ATM does not seem to be required to the
localization of Mrel 1 to sites of DSBs (Mirzoeva and Petrini 2001). The Mrel 1 complex

can still localize to dysfunctional telomeres in cells treated with caffeine, which inhibit
both ATM and ATR (Takai et al. 2003), further indicating a role in the sensing of DNA
damage. This requirement of the Mrell complex for Atm function has been
demonstrated by others (Carson et al. 2003; Uziel et al. 2003).
Deficiencies in the components of the Mrell complex lead to human
chromosome instability syndromes. Nbsl is mutated in patients with Nijmegen breakage
syndrome (NBS) (Varon et al. 1998). This rare, autosomal recessive genetic disease
results in microencephaly, growth defects, immunodeficiency, and an increased risk of
cancer. NBS has been classified as a disorder related to A-T based on the properties of
cells from NBS patients and it is interesting that both Nbsl and ATM play a role in the
DNA damage response. The discovery that Mrel 1 is mutated in patients with an ataxiatelangiectasia-like disorder (ATLD) suggests an even closer link between the Mrell
complex and ATM (Stewart et al. 1999). ATLD is a disorder in which patients have a
clinical syndrome resembling A-T, but have wild type ATM. Although Rad50 has not
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currently been associated with a chromosome instability disorder, the growth defects and
cancer predisposition of knockin mice expressing the Rad50S allele of Rad50 suggest
that mutations in Rad50 could lead to human disease (Bender et al. 2002).

Y-H2AX

H2AX has been proposed to play an important role in the mammalian DNA
damage response. Each nucleosome contains eight proteins with two proteins each from
the families H2A, H2B, H3, and H4. H2AX is one of the H2A subfamilies (H2A1-H2A2
and H2AZ are the others) and H2AX represents 2 - 25% of cellular H2A in mammalian
cells and virtually all of the H2A in yeast. The difference between H2AX and the other
family members is a motif that contains residue serine 139, which is phosphorylated by
ATM in response to IR (Rogakou et al. 1998; Burma et al. 2001). This response occurs
within one minute of damage and it maximal after ten minutes post-IR. Calculations
indicate that approximately 2 x 103 kilobases of DNA contain phosphorylated H2AX per
DSB and points to models where large chromatin domains are formed at sites of DSBs
(Rogakou et al. 1998; Rogakou et al. 1999).

The ATM pathway and DSB repair

A-T cells have a diminished ability to survive ionizing radiation (IR) and other
genotoxic treatments that create double-strand breaks ((Taylor et al. 1975); reviewed in
(Shiloh 2003)). This phenotype could be due to either checkpoint deficiency or
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inadequate D N A repair or both. A-T patients are proficient in N H E J as evidenced by
their normal V(D)J recombination (Hsieh et al. 1993). However, A-T patients show

aberrant interlocus recombination events in the T-cell receptor locus (Aurias et al. 1980;
Lipkowitz et al. 1990), potentially leading to translocations that promote
lymphomagenesis. A defect in the regulation of DNA repair pathways is also suggested
by the fact that A-T cells show an error-prone hyperrecombination phenotype, have
increased rates of chromosome mis-rejoining after damage, and have a high rate of
spontaneous telomere fusions ((Luo et al. 1996), reviewed in (Kojis et al. 1991)).
Furthermore, A-T cells have increased rates of intrachromosomal recombination (Meyn
1993) and several ATM targets have been implicated in homologous recombination (HR)
(e.g. BRCA1, FANCD2, and the Mrell complex (reviewed in (Petrini 2000; Jasin 2002;
Moynahan 2002; D'Andrea and Grompe 2003)). However, in other settings, ATM
deficient cells show impaired HR (Takao et al. 1999; Morrison et al. 2000) or have
normal rates of sister chromatid exchanges (SCEs) (Galloway and Evans 1975; Galloway
1977), which are thought to be generated by HR (Sonoda et al. 1999). Thus, the exact
role of ATM signaling in the regulation of NHEJ and HR is still poorly defined.
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Part II: Rifl and telomere biology

Telomeres: Discovery and Basic Structure

Telomeres are functional elements at the physical ends of eukaryotic
chromosomes. Early observations hinted that telomeres play an important role in
chromosomal stability and maintenance. In the late 1930's, H.J. Muller observed that
terminal deletions and inversions were not recovered in the offspring of X-ray irradiated
Drosophila males (Muller 1938). At about the same time, McClintock examined broken
chromosomes in maize. She noticed the resulting formation of dicentric chromosomes
and the subsequent loss breakage of these fused chromatids during cell division
(McClintock 1941). McClintock suggested that telomeres act to prevent fusion and
breakage events in intact, linear chromosomes. Taken together, these experiments laid

the foundation for the protective role of telomeres in eukaryotic cells. It is now clear th
telomeres serve to protect the ends of linear chromosomes from being recognized as
DNA damage.
Telomeres consist of tandem, repetitive, G+C-rich sequences. The G-rich strand
runs 5' - 3' towards the end of the chromosome. The actual telomeric repeat sequence
varies between species and these repeats can be either homogeneous or heterogeneous.
Telomere length ranges from 30 bp in Euplotes and Oxytricha to 250 - 400 bp in
Saccharomyces cerevisiae to 2 - 30 kb in humans. Murine chromosomes contain even
longer telomeres, but have the same TTAGGG double-stranded telomeric repeat as
human chromosomes. Typically, telomeres also have a 3' overhang of the G-rich
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telomeric strand, which is approximately 150 nucleotides at human chromosome ends.
Telomeric repeats are occasionally found at interstitial sites in eukaryotic genomes where
they may represent the remnants of ancestral chromosomal fusion events.
An early dilemma in the telomere field arose from the characterization of the
strategy of DNA replication. The so-called "end-replication problem" results from the
inadequacy of the replication machinery to complete lagging strand synthesis due to a
requirement for an RNA primer (Watson 1972; Olovnikov 1973). This inability of the
replication machinery to copy the ends of linear chromosomes results in a loss of
sequence at the telomere in the absense of mechanisms to synthesize additional telomeric
repeats (Levis 1989; Lundblad and Szostak 1989; Johnson et al. 2001). The loss of

telomeric repeats ultimately leads to a critically short telomere that is unable to protect
the end from DNA damage and other signaling pathways, which results in senescence or
apoptosis (as discussed below).
One solution to this problem came with the discovery of telomerase. Blackburn
and Greider identified a telomere synthesizing activity, now known as telomerase
(Greider and Blackburn 1985). Telomerase is a ribonudeoprotein that uses its essential
RNA component, called the telomerase RNA component (TERC, TR or TER), as a
template for the synthesis of tandem repeats on the G-rich strand (Greider and Blackburn
1989; Shippen-Lentz and Blackburn 1990; Singer and Gottschling 1994; Feng et al.
1995). The protein component of core telomerase, called telomerase reverse transcriptase
(TERT), uses the TERC template to synthesize additional telomeric repeats (Lingner et
al. 1997; Meyerson et al. 1997; Nakamura et al. 1997). Telomerase provides a solution to
the end-replication problem by adding additional telomeric sequences.
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Although most unicellular organisms have constitutive telomerase activity,
telomerase is tightly regulated in human cells. Human somatic cells have suppressed
telomerase activity, whereas ovaries, testis, and various proliferating cell populations
such as stem cells have telomerase activity (Kim et al. 1994; Meyerson et al. 1997;
Nakamura et al. 1997). The protein component, TERT, rather than the RNA component,
TERC, is the limiting component responsible for the suppression of telomerase in
somatic cells (Feng et al. 1995). The transcriptional suppression of the protein
component of telomerase occurs through a number of individual pathways, including
Menin, the Mad/Myc pathway and the TGFp target Sipl (Lin and Elledge 2003). This
ensures that the loss of any one pathway will not result in spurious telomerase activity.
The exact regulation of telomerase in terms of the timing of telomere repeat addition is
still being investigated. It is thought that telomere addition takes place during S phase.
The observation that Est2p, the telomerase protein component in S. cerevisiae, is found in
telomeric chromatin during S phase is consistent with S phase telomere repeat addition
(Taggart et al. 2002). However, telomerase is competent to extend telomere-like
substrates in mitosis (Diede and Gottschling 1999; Taggart et al. 2002). Est2p is also at
telomeres in Gl (Taggart et al. 2002).
Exogenous expression of hTERT in primary human fibroblasts is sufficient to
reconstitute telomerase activity and counter-act telomere erosion. The resulting telomere
maintenance immortalizes most human cells types (Bodnar et al. 1998; Vaziri and
Benchimol 1998; Ramirez et al. 2001). Like primary cells, tumor cells require a telomere
maintenance system for long-term proliferation and in the majority of cases this is
provided by upregulation of hTERT (reviewed in (Cong et al. 2002)). Other tumor cells
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maintain their telomeres through telomerase-independent pathways. This mechanism is
known as alternative lengthening of telomeres (ALT), although it is unclear whether there
are one or more such pathways (discussed below). Telomerase activity per se does not
induce transformation (Morales et al. 1999) and although telomerase is necessary for
immortalization, hTERT is not an oncogene (Hahn et al. 1999; Hahn et al. 2002).
Additionally, oncogenic transformation per se does not require telomerase activity and
cells with very long telomeres can be fully transformed into a tumorigenic phenotype in
vitro without a telomerase maintenance system (Seger et al. 2002). Similarly, certain
childhood tumors that originate in young cells with long telomeres can be cancerous and
metastatic even though they lack telomerase (Hiyama et al. 1995). However, the
extensive proliferation of cells during the prolonged multi-step tumorigenesis pathways
that leads to most adult human cancers is predicted to exhaust the telomere reserve,
necessitating telomerase activation (Hiyama et al. 1995). Thus, telomere maintenance,

particularly through telomerase activity, plays a critical role in facilitating tumorigenes

Telomerase and telomerase-binding factors

The telomerase RNA and reverse transciptase component of telomerase that
together form the core telomerase enzyme required for catalysis in vitro are not the only
components of the telomerase holoenzyme. In addition to core TLC1 and Est2p in S.
cerevisiae, Estlp and Est3p are also part of the telomerase holoenzyme and both estl and
est3 strains display the progressive telomere shortening phenotype, known as ever shorter
telomeres (est) (Lundblad and Szostak 1989; Lendvay et al. 1996; Hughes et al. 2000).
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Additionally, T L C 1 is also associated with S m proteins in S. cerevisiae (Seto et al. 1999).
The human telomerase holoenzyme also contains components other than the core RNA
and reverse transcriptase. Two orthologs of EST1, EST1A and EST IB, have been
identified and shown to be found in the telomerase holoenzyme (Reichenbach et al. 2003;
Snow et al. 2003). Orthologs of Est3p in humans have not been identified and there is no
data that Sm proteins bind TERC in humans.
Another component of the human telomerase holoenzyme is the protein dyskerin
(Mitchell et al. 1999b). TERC contains an H/ACA motif which dyskerin is able to bind
(Mitchell et al. 1999a). The X-linked form of dyskeratosis congenital, DKC, which
includes abnormal skin pigmentation, nail dystrophy and mucosal leukoplakia, is due to a
mutation in dyskerin while the autosomal dominant form is due to mutations in the
hTERC gene (Mitchell et al. 1999b).

Telomerase-independent telomere maintenance pathways

Telomere length can be maintained through mechanisms that do not depend on
telomerase. One type of telomerase-independent telomere maintenance pathway involves
recombination. The majority of estl 5. cerevisiae cells die in culture, but a minor
population of cells manages to survive (Lundblad and Blackburn 1993). The ability of
estl survivors to appear was critically dependent on RAD52 function, which implied a
recombination-based mechanism to the S. cerevisiae survivor pathway (Lundblad and
Blackburn 1993). It was subsequently shown that two types of survivors formed, termed
type I and type II survivors, and that these survivors were dependent on RAD51 and
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R A D 5 2 , respectively (Teng and Zakian 1999). Type I survivors are characterized by
extensive amplification and dispersal of sub-telomeric Y' elements to most telomeres and
type II survivors are characterized by a long telomeric tract (Teng and Zakian 1999). In
competition experiments, telomerase-positive wild type cells outgrow telomerasedeficient survivors (Morris and Lundblad 1997).
Although the majority of immortalized and cancer cells in humans use upregulation of telomerase for telomere maintenance (Shay 1997), a subset of immortalized
cells lack detectable telomerase activity (Bryan et al. 1995; Bryan et al. 1997a; Bryan et
al. 1997b; Bryan and Reddel 1997). These cells seem to maintain their telomeres through
one or more recombination-mediated mechanisms similar to the survivor pathway in 5.
cerevisiae. ALT cells have long, heterogeneous telomeres and contain ALT-associated
PML bodies (APBs) (Henson et al. 2002). APBs contain RAD51, RAD52, telomeric
DNA and known telomere binding proteins (Yeager et al. 1999). The role of APBs in the
ALT remains unclear.
Additional telomerase-independent mechanisms of telomere maintenance are
present in certain circumstances. In the absence of telomerase, S. pombe is able to
survive with three circularized chromosomes (Naito et al. 1998). This pathway is
presumably not available to either S. cerevisiae or mammalian cells because of their
higher number of chromosomes. Another mechanism of telomerase-independent
telomere maintenance is the transposon-mediated telomere maintenance that occurs
normally in Drosophila (Danilevskaya et al. 1994; Cenci et al. 1997; Danilevskaya et al.
1998).
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T h e discovery of cis-acting telomere-binding factors

Studies of telomerase confirmed the idea that eukaryotic cells have proteins that
bind specifically to telomeric DNA. Yu et al. mutated the RNA component of
Tetrahymena telomerase in vivo and noticed a deprotected telomere phenotype due to the
change in the sequence of the telomeric DNA, consistent with the requirement for a
sequence specific telomere binding protein (Yu et al. 1990). A similar phenomenon was
observed in the budding yeast Kluyveromyces lactis (McEachern and Blackburn 1995).
A number of groups identified sequence-specific telomeric DNA binding proteins,
including the a/fj telomere binding proteins in Oxytricha, Rapl in the budding yeasts S.
cerevisiae and K. lactis, Tazl in S. pombe (Berman et al. 1986; Price and Cech 1987;
Larson et al. 1994; Cooper et al. 1997). The de Lange lab first discovered TRFI
(TTAGGG repeat binding factor 1) and TRF2, the telomeric DNA binding proteins in
vertebrates (Chong et al. 1995; Broccoli et al. 1997b).
The discovery of TRFI and TRF2 led to insights into how telomere length is

maintained within given limits in telomerase positive cells (telomere length regulation) as
well as how human chromosome ends are protected. TRF2 plays a critical role in the
prevention of telomeric ends from being recognized by cells as double-stranded breaks.

Expression of a dominant negative allele of TRF2 in cells leads to the loss of telomeric 3'
overhangs, chromosome fusion, cell cycle arrest, p53/ATM-dependent apoptosis, or a
senescence-like state (van Steensel et al. 1998; Karlseder et al. 1999). Thus, the TRFs
seem to be essential for this important function of telomeres. The over-expresssion of
TRFI and TRF2 using the tetracycline-inducible system resulted in gradual telomeric
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shortening (van Steensel and de Lange 1997; Smogorzewska et al. 2000). Expression of
a dominant negative TRFI allele results in telomere elongation. This allele does not
affect the activity of telomerase in cell extracts, which suggests that TRFI regulates
telomere length in cis. A number of other factors have been identified as proteins that
associated with telomeres (Figure 1-2). The protein protector of telomeres 1 (POT1) was
identified in human cells and initially shown to protect telomeric ends (Baumann and
Cech 2001). POT1, which binds to single-stranded telomeric DNA, plays a role in
telomere length regulation by acting as a telomerase-dependent positive regulator of
telomere length (Loayza and De Lange 2003). Since POT1 binding can be affected by
the TRFI complex, POT1 may act as a transducer of TRFI signalling to control telomere
length (Loayza and De Lange 2003).
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Figure 1-2. Factors that bind to mammalian telomeres.
The following factors have been described as being found at telomeres in mammalian
cells. This figure does not show POT1, which can bind to both the TRFI complex and to
the 3' G-rich overhang. Figure courtesy of Titia de Lange (de Lange 2003).
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T-loops

Mammalian telomeres form structures termed t-loops that result from strand
invasion of the 3' overhang into the telomeric duplex DNA (Griffith et al. 1999). A
similar structure exists in the ciliate Oxytricha, in the typanosome T. brucei, and in the
plant A, thaliana (Murti and Prescott 1999; Munoz-Jordan et al. 2001). Incubation of a
telomeric model containing 3 kb of non-telomeric DNA followed by 0.5 kb of telomeric
DNA with baculovirus-derived human TRF2 increases the rate of formation of t-loops
(Griffith et al. 1999). T-loops are observed in isolated psoralen-crosslinked telomeric
DNA (Griffith et al. 1999). A preliminary model predicts that TRFI and TRF2 aid in the

formation of t-loops in vivo. TRFI, because of its spatial and orientational flexibility in
binding telomeric DNA, brings together regions of the duplex DNA array and TRF2
facilitates the invasion of the G-rich 3' overhang (Bianchi et al. 1999; Griffith et al.
1999).

The telomeric complex in Saccharomyces cerevisiae: Rapl and its binding factors

Raplp is the predominant telomeric binding protein in S. cerevisiae. Berman et
al. first identified the presence of a yeast protein that could bind telomeric repeats
(Berman et al. 1986). This factor turns out to be Rapl (Repressor and Activator Protein
1) (Longtine et al. 1989). Different labs independently identified factors identical to
Rapl known as TBA, GRF1 or TUF1 that bound a number of DNA sequences and play a
role in silencing at the mating-type loci, transcriptional activation of ribosomal protein
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genes, and transcriptional regulation of other genes (Shore and Nasmyth 1987; Vignais et
al. 1987; Buchman et al. 1988; Chambers et al. 1989). Rapl is an essential gene in yeast
that encodes an abundant 120 kD nuclear protein that is similar to the mammalian
transcription/replication factor NF1 and the yeast ARS-binding protein ABF1 (Shore and
Nasmyth 1987; Buchman et al. 1988; Santoro et al. 1988; Diffley and Stillman 1989)).
The consensus binding site for Rapl is 5'-AAYCCRYNCAYY-3' which occurs
approximately every 18 bp within yeast telomeric DNA allowing approximately twenty
copies of Rapl to associate with each chromosome (Gilson et al. 1993).
Rapl plays a significant role in yeast telomeric function. Rapl is found in
telomeric chromatin and is located at telomeres by indirect immunofluorescence (Conrad
et al. 1990; Klein et al. 1992). Telomere shortening occurs when yeast cells with
temperature-sensitive Rapl mutations are grown at semipermissive temperature (Lustig
et al. 1990). These mutations are recessive with respect to the wild type allele.
Overexpression of full-length Rapl results in a slight, dose-dependent telomere
elongation, increased length heterogeneity, and increased rates of recombination and
chromosome loss (Conrad et al. 1990). The expression of C-terminal truncation Rapl
mutants leads to telomere elongation, highly unstable telomeres susceptible to rapid
deletion, and chromosome nondisjunction rates that are 15- to 30- fold higher than wild
type levels (Kyrion et al. 1992).
Rapl functions to recruit other proteins to the yeast telomere. Two-hybrid
studies using the C-terminus of Rapl were used to identify two sets of proteins, the SIRs
(Sir3p and Sir4p) and the RIFs (Riflp and Rif2p) (Hardy et al. 1992; Moretti et al. 1994;
Cockell et al. 1995; Liu and Lustig 1996; Wotton and Shore 1997). SIR (Silent
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Information Regulator) proteins are required for silencing at H M mating-type loci and
telomeres. Sir3p and Sir4p colocalize with Rapl at telomeres by indirect
immunofluorescence and FISH using telomeric repeat probes (Gotta et al. 1996). Sir3p
no longer colocalizes with Raplp in sir4~ cells and Sir4p no longer colocalizes in sir3~
cells (Gotta and Gasser 1996). Sir3 and Sir4 are not required for telomere length
regulation or telomere protection.
The Rifs (Rapl-Interacting Factors), Rifl and Rif2, play a direct role in telomere
length regulation. Overexpression of either Rifl or Rif2 leads to telomere shortening and
overexpression of Rifl and Rif2 reverses the elongation seen with overexpression of the
C-terminus of Rapl (Wotton and Shore 1997). Thus, telomere length changes resulting
from overexpression of wild type or mutant Rapl alleles may result from titrating Rifl
and Rif2 away from the telomere. A more extensive introduction to Rifl is given in the
introduction sections of chapters 1 and 2. A major portion of this thesis focuses on the
identification and characterization of the human ortholog of yeast Rifl.
Deletion analysis using gel shifts of telomeric oligonucleotides indicated that the
minimal DNA-binding domain (DBD) of Rapl lies between amino acids 361 and 596
(Henry et al. 1990). The crystal structure of the Rapl DBD with an 18 nucleotide
telomeric DNA fragment shows that Rapl binds DNA with two myb-like HTH motifs
(Konig et al. 1996). The vertebrate telomeric-binding proteins TRFI and TRF2 and the
S. pombe protein Tazl also use myb domains to bind DNA (Bianchi et al. 1997; Broccoli
et al. 1997a; Cooper et al. 1997). There are important differences in the way Rapl and
TRFs bind their consensus sequences. Rapl binds to DNA with two myb-like motifs in a
single polypeptide, whereas TRFI and TRF2, each having only a single C-terminal Myb
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domain, homodimerize in order to bind D N A with two M y b domains (Bianchi et al.
1997; Broccoli et al. 1997b). The existence of two nearly adjacent Myb domains within
each Rapl molecule confines the protein to recognize two tandem sites in yeast telomeric
DNA. In contrast, the TRFI homodimer is able to bind two 5'-YTAGGGTTR-3' half-

sites with spatial and orientational flexibility (Bianchi et al. 1999). This flexibility may
serve a tethering function in establishing higher order DNA structures.

The TRFI complex: TRFI, Tankyrase, Tin2, and PinXl

In human cells, the TRFI complex acts as a negative feedback control system in
the regulation of telomere length. Telomerase-positive cells often have stably maintained
telomere length. This telomere length "set-point" varies between cells lines and even
between subclones of a given cell line. In order to initially study telomere length,
individual clones were analyzed by using an inducible gene expression system to regulate
the amount of TRFI alleles in cells (van Steensel and de Lange 1997; Smogorzewska et
al. 2000). The idea behind this negative feedback control system is that TRFI binds
along the length of duplex telomeric DNA and exerts a negative regulatory influence on
telomerase. If the telomere shortens, less TRFI will bind to the telomere and telomerase
can more easily act to lengthen the telomere. Conversely, telomere lengthening results in
increased TRFI binding and diminished ability for telomerase to lengthen longer
telomeres. The observations that the TRFI IF signal increases with telomere length
(Smogorzewska et al. 2000) and that a comparable percentage of telomeric chromatin is
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immunoprecipitated with T R F I in ChIP experiments regardless of telomere length
(Loayza and De Lange 2003) are consistent with this model.
The binding of TRFI to telomeres can be inhibited by two related enzymes,
tankyrase 1 and 2 (Smith et al. 1998; Smith and de Lange 2000; Kaminker et al. 2001;
Cook et al. 2002; Sbodio et al. 2002; Seimiya and Smith 2002). The takyrases are
poly(ADP-ribose) polymerases (PARPs), that were originally identified as TRF1interacting proteins. Tankyrases can ADP-ribosylate TRFI in vitro and in vivo and this
modification diminishes the ability of TRFI to bind to telomeric DNA in vitro (Smith et
al. 1998). Ectopic expression of tankyrase 1 in the nucleus results in the removal of
TRFI from telomeres in vivo (Smith and de Lange 2000; Cook et al. 2002; Loayza and
De Lange 2003). Consistent with these findings, overexpression of tankyrase 1 leads to
telomere elongation, the phenotype seen upon TRFI inhibition. TRFI also binds to Tin2
and PinXl. Tin2 is able to form a ternary complex with TRFI and tankyrase (Ye, J. and
de Lange, T., in press). PinXl has been proposed to inhibit telomerase directly in order
to participate in telomere length regulation (Zhou and Lu 2001). The proposed role of
PinXl differs dramatically from the cis-acting mechanisms proposed for TRFI, tankyrase
and Tin2.

The end of the telomere: CDC13 and Potl

The Cdcl3 protein in S. cerevisiae plays a critical role in the regulation of
telomere length maintenance and telomere protection through its actions at the most distal
part of the telomere; namely, the telomere terminus. Although CDC 13 was initially
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identified as a gene essential for cell division cycle (Garvik et al. 1995), it was
subsequently identified as one of several genes whose mutation leads to an ever shorter
telomere (est) phenotype, similar to the loss of telomerase (Lendvay et al. 1996). Cdcl3
is able to bind to the G-rich single-stranded overhang and acts by recruiting telomerase
through an interaction with Estl (Garvik et al. 1995; Nugent et al. 1996). Indeed, there is

an allele specific suppression of the cdcl3-2es' mutant (which is a loss-of-function mutant
resulting in an est phenotype) by an estl-60 mutant (which also displays an est
phenotype), consistent with a physical interaction between Cdcl3 and Estl (Pennock et
al. 2001). The proposed model underlying this genetic data is that a role of Cdcl3 at the
telomere is to recruit telomerase. In fact, a fusion between the DNA-binding domain of
Cdcl3 and Est2, the protein component of core telomerase, rescues the inability of
cdcl3-2esl and estl-A strains to maintain their telomeres (Evans and Lundblad 1999;
Pennock etal. 2001).
In addition to the ability of Cdcl3 to recruit telomerase to the telomere in 5.
cerevisiae, Cdcl3 also recruits additional factors that limit telomere elongation. In

particular, Cdcl3 recruits the protein Stnl and mutations in either CDC 13 that fail to bin
Stnl or STN1 mutations result in telomere elongation (Chandra et al. 2001; Grandin et al.
2001). One such CDC13 mutant, cdcl3-5, results in increased telomere length and
excessive G-strand overhangs in late S phase that become duplex with delayed kinetics
(Chandra et al. 2001). This suggests a defect in the co-ordination of lagging strand
synthesis with telomere elongation. The observation that Stnl suppresses both the
telomere elongation and G-stand overhang phenotype points to Stnl as the cause of these
phenotypes.

40

P 0 T 1 , a factor distantly related to Cdcl3, binds to the telomere terminus in S.
pombe and human cells. This gene was first discovered in the fission yeast S. pombe and
was shown to bind to the G-rich strand of telomeric DNA in vitro (Baumann and Cech
2001). Potl binds to telomeric DNA through an OB fold that resembles that of the
telomere binding protein Oxytricha a and Cdcl3 (Baumann and Cech 2001; Mitton-Fry
et al. 2002). The binding of Potl to the S. pombe telomeric DNA occurs in a cooperative
fashion (Lei et al. 2002). Deletion of the potl-i- gene results in chromosome instability,
as demonstrated by a mis-segregation phenotype, as well as the loss of telomeric DNA
and subsequent circularization of chromosomes (Baumann and Cech 2001). Hence the
name Potl, protector of telomeres 1, was given because Potl plays a critical role in
protecting telomeres.
A human ortholog of Potl was identified and characterized. Human Potl colocalizes with known telomere proteins in immunofluorescence experiments (Baumann et
al. 2002). Additionally, human POT1 is also able to bind to telomeric DNA in vitro
(Baumann et al. 2002) and is present at telomeres in vivo based on ChIP (Loayza and De
Lange 2003). The amount of POT1 on telomeres was reduced when the quantity of
single-stranded telomeric DNA was reduced (Loayza and De Lange 2003; Loayza et al.
2004). Furthermore, a deletion of the POT1 DNA-binding domain results in rapid
telomere elongation (Loayza and De Lange 2003). Since POT1 interacts with the TRFI
complex, it has been proposed that TRFI sends information about telomere length to
POT1 at the telomere terminus, which regulates either the recruitment or access of
telomerase to the telomere terminus (Loayza and De Lange 2003).
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h R a p l and spRapl as orthologs of scRapl

A search for TRF2-interacting proteins using a yeast two-hybrid approach has
uncovered a factor, termed hRap, that has significant sequence identity to Rapl in S.
cerevisiae (Li et al. 2000). hRapl encodes a 47-kD, 399-amino acid protein that contains
an N-terminal BRCT domain, a Myb-type domain, and an acidic C-terminus (Figure 1-3).
These domains in hRapl have approximately 25% sequence identity and 50% sequence
homology to their respective domains in scRapl (Figure 1-3). Thus, hRapl seems to be
an ortholog of scRapl.
Further analysis reveals that hRapl plays a role at human telomeres. Northern
analysis reveals a 2.5 kb band that is widely expressed in human tissues. Indirect
immunofluorescence using an anti-hRapl antibody in HeLa cells, HT1080 cells, and
IMR90 cells shows punctuate nuclear staining. hRapl colocalizes with TRF2 and TRFI
in cells and immunofluorescence of metaphase chromosomes shows a signal only at
chromosome ends. Using a tetracycline-inducible system in telomerase-positive HTC75
cells (derived from HT1080 cells), inducible overexpression of full-length FLAG-tagged
hRapl results in the gradual elongation of telomere length (Li et al. 2000). Surprisingly,
hRapl does not appear to bind directly to telomeric DNA, though it can supershift TRF2telomeric DNA complexes (Li et al. 2000).
A more thorough discussion of the domain structure and the importance of hRapl

is found in the introductions to chapters 1 and 3 of this thesis. Since one of the projects

in this thesis is the identification of novel Rapl-interacting factors, this topic is discu
in depth along with the data in chapter 3.

42

T h e T R F 2 complex: T R F 2 , hRapl, and the Mrell complex

The protein complex associated with TRF2 plays a critical role in telomere length
regulation and end protection. Studies of the proteins found in TRF2 immunoprecipitate
pellets resulted in the identification of the Mrel 1 complex, consisting of Mrel 1, Rad50,
and Nbsl (Zhu et al. 2000). As discussed earlier in this introduction, the Mrel 1 complex
plays a role in a variety of biological functions including recombination and DNA
damage repair. Components of the Mrell complex co-localized with known telomere
proteins (Zhu et al. 2000). Additional studies of TRF2-interacting factors resulted in the
identification of ERCC1 and XPF in the TRF2 complex (Zhu, X, et al., submitted).

Human Rapl and the evolution of the telomere complex

The identification of hRap 1 raises important questions regarding the evolution of
telomeric complexes. A contradiction seems to exist between the structure and function
of Rapl in vertebrates and budding yeast. S. cerevisiae utilizes Rapl to bind directly to
telomeric DNA while, in humans, Rapl does not bind telomeric DNA and associates with
the telomere via its interaction with TRF2. S. cerevisiae lacks a TRF-like component at
their telomeres. What factors were contained in the "ancestral" telomeric complex?
Further examination of known telomeric protein similarities suggests a possible

resolution to this problem. The major binding factor in the fission yeast, S. pombe, is the
protein Tazl. Although no ortholog of Rapl is currently known in S. pombe, Tazl can be
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Figure 1-3. Domain stucture and sequence alignments of h u m a n Rapl.
The domain stucture of hRapl is given in A. The protein structure is given in C. D, E
and F depict alignments of the B R C T domain, M y b domain, and R C T domains,
respectively. G illustrates the conservation of the various domains between human Rapl
and yeast Rapl. Figure courtesy of Titia de Lange (Li et al. 2000).
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classified as a member of the T R F family of proteins (Li et al. 2000). The M y b domain
of Tazl more closely resembles the Myb domains of the TRFs than the Myb domains of
Rapl. Tazl also contains a central TRFH (TRF homology) domain (Li et al. 2000). The
TRFH domain acts as a dimerization domain in TRFI and TRF2 (Bianchi et al. 1997;
Broccoli et al. 1997b; Fairall et al. 2001) A model emerges in which the "ancestral"
telomeric complex contains both a TRF-like component and a Rapl-like component.
Budding yeast, including C. albicans, K. lactis and 5. cerevisiae, seemed to have lost the
TRF component. In support of this, the budding yeast has a more divergent telomeric
repeat than the TTAGGG found in vertebrates (most lower organisms have telomeric
repeats that very closely resemble TTAGGG). Possibly a mutation in the telomerase
RNA template resulted in a change in the telomeric template and the ability of Rapl to
bind to this new telomeric repeat enabled the budding yeast to remain viable (Li et al.
2000). Further discussion of how the discovery and characterization of Rapl and Rifl in
S. pombe add to this picture of evolution and the roles of these proteins in telomere
biology is reserved for the introductions of later chapters.

DNA damage response factors and telomeres

A number of DNA damage response factors are involved in telomere length
maintenance. Telomere maintenance and length control in S. pombe are influenced by
the DNA damage response factors Radl7, Rad53, Mec3 and Ddcl (Dahlen et al. 1998;
Longhese et al. 2000; Nakamura et al. 2002). Additionally, in both S. cerevisiae and S.
pombe, the deletion of the NHEJ factor Ku leads to very short, but stable, telomeres

45

(Porter et al. 1996; Boulton and Jackson 1998; Gravel et al. 1998; Nugent et al. 1998;
Polotnianka et al. 1998; Baumann and Cech 2000). This phenotype is unrelated to the
loss of NHEJ in cells, as the loss of DNA ligase IV, another factor involved in NHEJ,
does not affect telomere length (Boulton and Jackson 1998; Baumann and Cech 2000).
Factors involved in the DNA damage response, including ATM, play a role in
telomere length maintenance in mammalian cells. Peripheral blood lymphocytes from AT patients show significant telomere shortening compared to age-matched donors
(Metcalfe et al. 1996). Also, cells from ATM deficient mice and A-T patients have
extrachromosomal telomeric DNA (Hande et al. 2001). The mechanism of ATM
regulation of telomere length maintenance and telomere stability is unknown.
The mechanism is also unclear for the role of Ku70/80, DNA-PK,.,;, and PARP-1
in telomere length maintenance. While DNA-PKCS null mice have normal telomere
length (Goytisolo et al. 2001; Espejel et al. 2002), mice with the DNA-PK^ SCID
mutation have been reported to have longer telomeres (Hande et al. 1999; Goytisolo et al.
2001). Perhaps the SCID mutation, while deficient in NHEJ, may be a gain of function
mutation for the role of DNA-PK^ in telomere length control. It is more difficult to
explain discrepancies in reports on Ku80. Even though two groups measured telomere
lengths in the same Ku86 null mouse strain, one report indicates shorter telomeres
(d'Adda di Fagagna et al. 2001), while another found no change (Samper et al. 2000).
Finally, mice lacking PARP-1 have shorter telomeres but this phenotype is only seen in
the absence of p53 (dAdda di Fagagna et al. 1999; Samper et al. 2001).

46

Consequences of telomere dysfunction and link to the D N A damage response

Telomeres prevent the ends of linear chromosomes from being recognized as
damaged DNA. Dysfunctional telomeres, which fail to protect chromosome ends, are
indeed recognized by the DNA damage response. The consequences of telomere
dysfunction are disastrous and potentially lethal for cells. Model systems for telomere
dysfunction can be generated by passaging primary cells, which lack telomerase, in
culture. Primary fibroblasts undergo telomere attrition and will enter into a type of
growth arrest known as senescence after a given number of passages in culture (Hayflick
1998). Senescence occurs when one or more telomeres have shortened to a certain
critical length and are unable to properly protect chromosome ends. The ectopic
expression of a dominant negative TRF2 allele lacking both the basic and Myb domains
(TRF2ABAM) also results in dysfunctional telomeres (van Steensel et al. 1998). The
following discussion will briefly describe the consequences of telomere dysfunction,
including apoptosis and senescence, and the recognition of dysfunctional telomeres by
the DNA damage response.
Dysfunctional telomeres resulting from the ectopic expression of TRF2ABAM result
in apoptosis and senescence, depending on cellular context. Telomere-telomere fusions
and anaphase bridges occur as a result of TRF2ABAM over-expression (van Steensel et al.
1998). Additionally, cells can also enter senescence (van Steensel et al. 1998;
Smogorzewska and de Lange 2002). Telomeric DNA is still detectable by Southern blot
and IF, which is consistent with the idea that TRF2ABAM results in telomere dysfunction
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because of structural changes in the telomere rather than loss of telomeric D N A .

The

telomere end-to-end fusions and anaphase bridges are consistent with dysfunctional
telomeres being recognized as DNA damage and subsequently being fused together by
the NHEJ repair pathway. The formation of telomere end-to-end fusions upon TRF2ABAM
over-expression is dependent upon ligase IV, a critical component of the NHEJ pathway
(Smogorzewska et al. 2002). Additionally, certain cells over-expressing TRF2ABAM can
undergo apoptosis in a manner dependent on ATM and p53 (Karlseder et al. 1999). The
formation of telomere dysfunction-induced foci (TIFs), wherein DNA damage response
factors accumulate at dysfunctional telomeres, provides further evidence that deprotected
telomeres induced by TRF2ABAM are interpreted by the cell as DNA damage (Takai et al.
2003).
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S u m m a r y and Relevance

This thesis deals primarily with the identification and characterization of human
Rifl, an ortholog of the telomere length regulator Rifl in S. cerevisiae and 5. pombe.
Chapter 1 describes the identification of human Rifl using a bioinformatics approach
where sequences from S. cerevisiae Rifl were used to query the human database. The
generation of antibodies led to the initial characterization of human Rifl. Chapter 1
describes efforts to implicate Rifl in human telomere biology. These efforts failed to
discern a definitive role for human Rifl in telomere biology. Immunofluorescence, coimmunoprecipitation and ChIP techniques were all used to determine if Rifl localizes to
telomeres, interacts with known telomeric proteins, or associates with telomeric
chromatin. Chapter 2 reports on the most significant and surprising discovery in this
thesis which is that Rifl plays a role in the DNA damage response in human cells. The
data demonstrate that Rifl forms foci in response to DNA damage. Rifl responded to
ionizing radiation (IR), UV light, and clastogens, forming foci that co-localized with
other DNA damage response factors such as 53BP1, ATM, BRCA1, Chkl, Nbsl, and
Rad 17. Furthermore, Rifl localized to uncapped telomeres, as do other DNA damage
response factors. Among DNA damage response proteins, Rifl showed a unique
dependence on the ATM kinase. Whereas inhibition of ATR signaling did not inhibit the
Rifl response, ATM deficient cells treated with IR or UV lacked Rifl foci even after
prolonged incubation or high radiation dose. Therefore, IR-induced Rifl foci constitute
an assay for ATM status. The Rifl response also depended on the presence of 53BP1 but
was not affected by reduced function of BRCA1, Chk2, Nbsl, and Mrell. RNAi-
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mediated Rifl inhibition resulted in increased radiosensitivity, indicating that Rifl
function contributes to the ATM-mediated protection against exposure to ionizing
radiation.
This thesis also focuses on the human TRF2 complex, which includes Rapl and
the Mrel 1 complex. Chapter 3 describes a yeast two-hybrid screen conducted using
Rapl as a bait to identify novel Rapl-interacting factors in mammalian cells. Two genes,
a novel gene called cDNA 144 and a previously identified gene called FLASH, were
identified in this screen. Neither cDNA 144 nor FLASH were shown to have a role in
human telomere biology.
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C h a p t e r 1 - Identification o f h u m a n
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Rifl

Introduction

The importance of yeast Rifl in telomere biology provided the impetus that led

to the identifications of a Rifl ortholog in human cells. Rifl was first discovered through
a yeast two-hybrid screen as a protein that binds to Rapl (Hardy et al. 1992).
Specifically, the C-terminal portion of Rif extending from amino acids 1614 to 1916
interacts wth the C-terminus of Rap 1 extending from amino acids 667 to 827 (Hardy et
al. 1992). The fact that there is allele-specific suppression of rapls mutants, which have
altered telomere length and do not bind Rifl, by the RIF1 allele rif 1-1 confirms the
biological significance of this interaction (Hardy et al. 1992).
Rifl plays a role in telomere length regulation, transcriptional silencing at the
yeast mating-type locus, and transcriptional silencing of telomere proximal genes, known
as the telomere position effect (TPE) (Hardy et al. 1992; Kyrion et al. 1993). Yeast onehybrid analysis suggests that S. cerevisiae (scRifl) associates with telomeric DNA in
vivo (Bourns et al. 1998). Deletion of RIF1 leads to mild telomere elongation that is
telomerase-dependent and RAD52-independent (Kyrion et al. 1993; Teng et al. 2000).
Rif2, which is not related to Rifl, also binds to the C-terminus of Rap 1 in S. cerevisiae
(Wotton and Shore 1997). Like deletion of RIF1, deletion of RIF2 leads to telomere

elongation and rifl rif2 strains have telomeres longer than either rifl or rif2 strains alo
(Wotton and Shore 1997; Mishra and Shore 1999).
While most S. cerevisiae cells that lack telomerase will die after 50-100
generations, survivors arise spontaneously and fall into two types (Lundblad and
Blackburn 1993). Type I survivors have a tandem repeat of the Y' element and very
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short tracts of telomeric repeat D N A , and type II survivors have very long and
heterogeneous tracts of telomeric repeat DNA. In culture, type I survivors frequently

convert to type II survivors and type II survivor telomeres return to wild-type length with
the re-introduction of telomerase (Teng and Zakian 1999). The distribution of type I and

type II survivors after loss of telomerase is affected by Rifl, as rifl tlcl cells result i
18% type II survivors whereas tlcl cells result in 6.5% type II survivors (Teng et al.
2000). The mechanism underlying the effect of Rifl on the survivor pathway in 5.
cerevisiae is currently unknown.
The discovery of S. pombe Rifl (spRifl) and analysis of its roles in telomere
biology reveal that scRifl and spRifl behave similarly in terms of telomere length
regulation. Deletion of spRifl also results in telomere elongation (Kanoh and Ishikawa
2001). As mentioned in the introduction, spRifl is recruited to telomeres through its
interaction with Tazl, whereas scRifl is recruited to telomeres through its interaction
with Rapl (Hardy et al. 1992; Kanoh and Ishikawa 2001).
Rifl, Rif2, Sir3 and Sir4 all compete for binding to the carboxy-terminus of Rapl
(Buck and Shore 1995; Mishra and Shore 1999). Furthermore, there is also competition
between Ku and Rifl in terms of telomeric silencing (Mishra and Shore 1999). This
competition may be the reason underlying a decrease of telomeric silencing seen in cells
lacking scRifl (Kyrion et al. 1993). S. pombe Rifl (spRifl) also plays a role in telomere
length regulation and TPE (Kanoh and Ishikawa 2001). S. pombe rifl" strains have
decreased spore viability and aberrant chromosome segregation which implies an
additional role for rifl in meiosis (Kanoh and Ishikawa 2001).
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Based on these findings, the identification of human Rifl was anticipated to
provide insight into human telomere function. The role of human Rifl (hRifl) could also
address issues related to the evolution of telomere protein complexes. In S. cerevisiae,
Rapl is the predominant double-stranded telomeric binding protein. Rifl is then
recruited to S. cerevisiae telomeres through its interactions with Rapl. In 5. pombe, Tazl
is the major protein that binds directly to telomeres. Rapl is recruited to telomeres
through its interaction with Tazl (Chikashige and Hiraoka 2001; Kanoh and Ishikawa
2001). 5. pombe Rifl is also recruited to telomeres by Tazl, but this recruitment is Rapl
independent (Kanoh and Ishikawa 2001). Thus, the interactions of the telomere proteins
differ in these two yeast species (Figure 1-1). The discovery of human Rapl and the
finding that Tazl in S. pombe is similar to human TRFI and TRF2 raises the question of
what role human Rifl may play in the human telomere complex (Li et al. 2000). Does
the human telomere complex resemble the complex in 5. cerevisiae where Rifl is
recruited to telomeres through Rapl or the complex in S. pombe where Rifl is brought to
telomeres through the TRF-like Tazl ?
This chapter focuses on the identification and initial characterization of a human
ortholog of yeast Rifl. hRifl was found using a bioinformatics approach where the
human genome and expressed sequence tags (ESTs) were queried with scRifl and
spRifl. Antibodies were generated against human Rifl in order to study this protein.

Since Rifl plays a role in telomere biology in both S. cerevisiae and S. pombe, a series of
experiments were conducted to address whether or not Rifl plays a role in human
telomere biology. An indirect immunofluorescence (IF) approach was taken to address
whether Rifl co-localizes with previously known human telomere proteins such as TRFI,
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T R F 2 , hRapl and Tin2. Additionally, attempts were made to co-immunoprecipitate Rifl
with known telomere complexes. Rifl was also found at other cellular locations in
human cells.
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Rifl

Rapl
—

>_
Human

Rifl

Fission yeast

Budding yeast

Figure 1-1. Evolution of the telomere complex.
The relationship among telomeric protein complexes in vertebrates, fission yeast, and
budding yeast. T R F 2 and Tazl are structurally related. In budding yeast, Rapl binds
telomeric D N A whereas human and fission yeast Rapl bind to telomeres via T R F 2 and
Tazl, respectively. Budding yeast Rifl binds to Rapl, whereas fission yeast Rifl binds
to Tazl. The role of Rifl at human telomeres is currently unclear. Figure courtesy of
Agata Smogorzewska and Titia de Lange.
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Results

A search for the human ortholog of yeast Rifl was undertaken due to its
importance in telomere biology. Initially, the S. cerevisiae Rifl protein sequence (Hardy
et al. 1992) was used to query the human database in a BLAST search. Using this
approach, a human ortholog of S. cerevisiae RIF1 was not detected. Then, S. cerevisiae
RIF1 sequence was used to query the S. pombe database using a BLAST search and an S.
pombe ortholog was identified (P value = 1 x IO"7). This gene was identical to S. pombe
Rifl gene later published as the functional ortholog of S. cerevisiae Rifl (Kanoh and
Ishikawa 2001). S. pombe Rifl was then used to identify a human Rifl ortholog using a
BLAST search (P =9 x IO"5, Unigene hypothetical protein FLJ10599). The DNA
sequence of human Rifl was assembled from the following overlapping clones in
Genbank: Homo sapiens cDNA FLJ12870 fis, clone NT2RP2003727 (Genbank
accession number AK022932); Homo sapiens cDNA FLJ10599 fis, clone
NT2RP2004959 (Genbank accession number AK001461); IMAGE clone 2187070 3' end
(Genbank accession number AI537278); and cDNA DKFZp434D193 (Genbank
accession number AL080129). The full DNA sequence of human Rifl is given in
Genbank accession number AY585745.
The predicted open reading frame of combined ESTs is 2472 amino acids
encoding a protein with a pi of 5.46 and a predicted MW of 274 kilodaltons (Figure 1-2).
The sequence similarity of hRifl to scRifl and spRifl was low (15% and 18% sequence
identity, respectively) but extended throughout the reading frame. The initial alignment
of S. cerevisiae, S. pombe and human Rifl using a CLUSTAL
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Figure 1-2. Alignment of h u m a n Rifl with mouse Rifl and fugu Rifl.
The human Rifl amino acid sequence is depicted and aligned with mouse Rifl and fugu
Rifl. Conserved amino acids are depicted in red and blue and a consensus sequence is
given below. The protein product of human Rifl is predicted to be 2472 amino acids.
The full D N A

sequence of human Rifl is given in Genbank accession number

AY585745.
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I and
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cerevisiae.
The CLUSTAL algorithm was used to align Rifl in 5. cerevisiae and human. A
schematic of human Rifl above depicts the three conserved regions of Rifl with
sequence conservation of 20-25%. The alignment shown depicts the first two conserved
regions of Rifl.
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Figure 1-4. Alignment of conserved region III of Rifl in h u m a n a n d 5. cerevisiae.
T h e C L U S T A L algorithm w a s used to align the C-terminal portions of Rifl in 5.
cerevisiae and h u m a n . T h e alignment depicts conserved region III.
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algorithm suggests more sequence similarity between the N-terminal regions and less
similarity between the C-terminal regions. Further analysis reveals three conserved
regions when human, mouse and fugu Rifl are aligned (Figure 1-2). These conserved
regions, designated CRI-III, have 20-25% conserved amino acids (Figures 1-3 and 1-4).
Secondary structure analysis revealed a series of conserved predicted helices between S.
cerevisiae, S. pombe and human Rifl proteins. The mammalian Rifl proteins are
composed almost entirely of Armadillo repeats. ARM repeat folds, which are composed
of three helices, often occur in long arrays and form an extended curved protein
interaction surface (Huber et al. 1997; Conti et al. 1998). The open reading frame
predicts a high density of helical segments in its N-terminal 800 amino acids, a putative
bipartite NLS sequence at position 2188 and a serine-rich region from position 11491204 (Figure 1-4 and 1-5A).
In order to understand the role of Rifl in human cells and determine whether or
not Rifl is associated with telomeres, antibodies were generated against hRifl. Two
types of antigens, KLH-conjugated peptides and GST-fusion proteins, were used to
produce antibodies (Figure 1-5A). The PROTEAN program in the Lasergene navigator
software package was used to predict the optimal peptides for antibody generation based
on the criteria of hydrophobicity and antigenicity (Figure 1-5B). Using the output, a total
of four peptides individually containing amino acids 773-798

(YNIKYQPKVKSPQRPSDWSKKKNEPC), amino acids 1552-1587 (NH2 NSESDSSEAKEEGSRKKRSGKWKNKC - COOH), amino acids 2077-2102 (NH2 EEGIIDANKTETNTEYSKSEEKLDNC - COOH) or amino acids 2448-2473 (NH2 LSCMANSVIKNLQSRWRSPSHENSIC - COOH) of hRifl were synthesized in vitro
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F i g u r e 1-5. Antibodies generated against h u m a n Rifl.
A . A schematic of h u m a n Rifl is s h o w n . Conserved regions I-III (black), the serine-rich
region (purple), and N L S (aqua) are s h o w n . T h e positions of the antigens used in
antibody generation are s h o w n (green).
B. T h e biochemical properties of the a m i n o acids in hRifl. T h e P R O T E A N p r o g r a m in
the Lasergene software package w a s used to generate the plots f r o m the hRifl protein
primary sequence. A combination of the antigenic index and the surface probability plot
w a s used to select the peptides that w o u l d be used as i m m u n o g e n s to generate antibodies
against hRifl.
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(Biosynthesis) and conjugated to keyhole limpet haemocyanin (KLH).

Each K L H -

conjugated peptide was used to immunize two rabbits (Covance) and the resulting sera
were affinity-purified. A carboxy-terminal cysteine was added to each peptide to allow
for conjugation to KLH. Table 1-1 below describes the various antibodies raised against
Rifl, including the antigens used and their efficacy in Western blots.

Serum
number

Antigen used

Peptide
positions

Affinity-purified?

1023

KLH-conjugated
peptide
KLH-conjugated
peptide
KLH-conjugated
peptide
KLH-conjugated
peptide
KLH-conjugated
peptide
KLH-conjugated
peptide
KLH-conjugated
peptide
KLH-conjugated
peptide
GST-Rifl
fragment fusion
GST-Rifl
fragment fusion

773-798

Yes

773-798

Yes

1552-1577

1024
1025
1026
1060
1061
1062
1063
1066
1067

Detection
of Rifl in
Western
blot

Non-specific
bands in
Western

Yes

++

+

1552-1577

Yes

++

+

2077-2102

Yes

+++

2077-2102

Yes

+

2448-2472

No

2448-2472

No

+ (weak)

1974-2472

No

+++

1974-2472

No

+++

Table 1-1. Characteristics of antibodies against h u m a n Rifl.
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+/-

+
+/-

The antibodies designated 1025 and 1060 recognized a single large (>250 kDa)
polypeptide in Western blots of HeLa cells, whereas preimmune serum did not recognize
this polypeptide (Figure 1-6A). The 1060 peptide antigen was also injected into mice to
generate a polyclonal mouse serum designated as mouse 1060. GST-fusion proteins were
also used to generate anti-Rifl antibodies. Proteins with an N-terminal GST fused to
portions of hRifl were made in order to generate antibodies. Four GST-fusion proteins
were constructed. The first two, from amino acids 177-797 and 177-907, designated
GST-hRif 1177.797 and GST-hRif 1,77.907, respectively, did not yield protein products
detectable by Coomassie staining. It is unclear if this was due to protein solubility,
stability, or some other factor. A GST-Rifl fusion containing amino acids 907-1327,

designated GST-hRif 1907.1327, was used as an antigen to generate the rabbit polyclonal ser
1066 and 1067 (Figure 1-5A). This GST-fusion protein was expressed in BL21 strain E.
coli and purified using glutathione-conjugated sepharose beads (Figure 1-6B). Another
GST-hRif 1 fusion containing Rifl amino acids 1974-2472, designated GST-hRif 11974.2472,
was produced (Figure 1-6B), but sufficient quantities for antibody production were
difficult to obtain. GST-hRifl90-7.1327 was used to immunize two rabbits and the resulting
crude sera, designated 1066 and 1067, reacted with the same large molecular weight
polypeptide as the previously described 1025 and 1060 (Figure 1-6A). Cells treated with
siRNAs corresponding to Rifl diminished the abundance of this protein (see Chapter 2),
confirming that this polypeptide is encoded by the Rifl gene and establishing the
specificity of the sera used in this study.
Human Rifl mRNA is greater than nine kilobases and is present in a wide variety
of tissues (Figure 1-7A). The Rifl protein was detectable in different human cell lines
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and strains (e.g. IMR90, G M 8 4 7 , VA-13, HeLa, U 2 0 S ) suggesting ubiquitous expression
(Figure 1-7B, see also below and Chapter 2). Thus, Rifl is found in all primary
fibroblasts, including IMR90 and BJ cells, and tumor cells, including HeLa and HT1080
cells. It is interesting to note that Saos-2 cells have diminished levels of hRifl whereas
other ALT lines such as GM847, U20S, and VA-13 cells have normal hRifl levels
(Figure 1-7B). It is unclear how and why this decrease in Rifl protein is observed with
these cell lines and it has not been determined if these cell lines have Rifl mutations at
the DNA level or if they fail to express Rifl mRNA. The inability of the Rifl antibodies
to detect Rifl in the murine NIH3T3 cells merely indicates that these antibodies do not
cross-react with mouse Rifl. Mouse Rifl does exist and studies to elucidate the role of
mouse Rifl in vivo are currently being performed (S. Buonomo, unpublished results,
(Adams and McLaren 2004)). As mentioned in the introduction, ALT resembles the
survivor pathways in yeast that lack telomerase. S. cerevisiae Rifl affects the
distribution between type I and type II survivors (Teng et al. 2000). The mechanism
underlying this is unclear, but a similar mechanism may be occurring in human ALT cells
where Rifl can inhibit the initiation or maintenance of ALT. This proposed mechanism
is still highly speculative. A subset of ALT cells, such as Saos-2, may actually require
the loss of Rifl in order to survive. The antibodies 1025 and 1067 fail to detect Rifl in
NIH 3T3 cells, indicating that they do not cross-react with mouse Rifl (Figure 1-7B).
HeLa cells in Gl, S, or G2/M phase obtained by centrifugal elutriation contained similar
amounts of Rifl protein (Figure 1-7C). FACS analysis of the individual elutriation
fractions which were pooled to generate the Gl, Gl/S, S and G2/M fractions is shown in
figure 1-7C.
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Figure 1-6.

Antibodies to h u m a n Rifl.

A. Detection of human Rifl protein. Immunoblots of HeLa whole cell extract probed
with the indicated antibodies or a pre-immune serum (1060 PI).
B. G S T fusion proteins. GST-fusion proteins containing G S T fused to either hRifl
amino acids 907-1327 or hRifl amino acids 1979-2296 were produced in BL21 strain E.
coli.
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Figure 1-7. H u m a n Rifl is expressed ubiquitously.
A. Rifl R N A levels in human tissues. A Rifl-specific sequence was used to probe a
multiple tissue northern blot (Clontech). R N A sources are indicated.
B. Immunoblotting of Rifl in multiple cell lines. Whole cell lysates were made from
HeLal.2.11, VA-13, G M 8 4 7 , Saos-2 and NIH-3T3 cells. Immunoblots were performed
using Rif antibodies 1025 and 1067. The tubulin immunoblot serves as a loading control.
C. Rifl expression throughout the cell cycle. HeLa cells were subjected to elutriation.
F A C S analysis was performed on the resulting fractons. Whole cell lysates were then
prepared from the pooled fractions as indicated. Immunoblotting was performed using
antibodies recognizing Rifl (1060) and tubulin. Elutriation and F A C S analysis were
performed by Jeffrey Y e and Lei Zheng.
reproducible.
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Indirect immunofluorescence (IF) with Rifl antibodies revealed a nuclear
staining pattern with most of the signal distributed in a fine granular pattern throughout
the nucleus of interphase cells (Figure 1-8A). We also observed one or a few nuclear
sites of more intense Rifl staining with the Rifl antibodies 1025, 1060, 1066, and 1067
(Figure 1-8A and Chapter 2). Cell cycle experiments using HeLa cells released from
double thymidine block were conducted in order to determine if these Rifl dots varied

during the cell cycle. Almost no cells displayed the intense dot pattern after release from
double thymidine block (Figure 1-9A and B). Between 50 and 70 percent of cells display
one or more intense Rifl foci after the 10 hr point (Figure 1-9A and B). This indicated
that these Rifl dots formed as cells exited mitosis and disappeared in S-phase. Rifl dots
did not co-localize with antibodies to coilin (a marker for Cajal bodies) and their nature
remains to be determined (Figure 1-10). Rifl was also found at the mid-body of the cell
and in the Golgi complex. The mid-body is a structure that forms at the point of cell
division as cells undergo cytokinesis and its exact role is unclear. The localization of
Rifl to the mid-body is seen with antibodies 1025 and 1060 (Figure 1-1 IA). Using antiRifl antibody 1025, Rifl co-localizes with the Golgi complex protein GM130 (Figure 11 IB). The localization of Rifl to the Golgi is only observed with antibody 1025, so it is

likely that this is actually an artifact or that 1025 cross-reacts with another protein tha
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Figure 1-8. Rifl does not accumulate at telomeres.
Rifl is a nuclear protein. Immunofluorescence (IF) of paraformaldehyde-fixed
HeLal.2.11 cells with mouse serum raised against Rifl antigen 1060 (green) and
antibodies against T R F I (371) and T R F 2 (647) (both red) along with D A P I staining
(blue).
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Figure 1-9. Cell-cycle distribution of Rifl dots.
A. HeLal.2.11 cells were synchronized using a double-thymidine block. Cells were then
released into media and fixed at the time points indicated. IF was performed on fixed
cells. Cells were stained with Rifl antibody (1060) and D A P I and the percentage of cells
with at least one Rifl-intense focus was determined by counting 200 cells. Each color
represents an independent count from the same experiment.
B. A micrograph of double thymidine arrested HeLal.2.11 cells treated as in A at 0 and
10.5 hr post-release as indicated. Cells were stained with Rifl 1060 (green).
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Figure 1-10. Rifl dots do not co-localize with Cajal bodies.
IF performed on HeLal.2.11 cells using antibodies against Rifl (green) and coilin (red)
along with D A P I (blue).
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B

Figure 1-11. Localization of Rifl to the mid-body and Golgi complex.
A. Rifl at the mid-body during telophase. IF was performed on paraformaldehyde-fixed
HeLal.2.11 cells. Cells were stained with Rifl 1060 (green) and DAPI.
B. Rifl in the Golgi complex. IF was performed on paraformaldehyde-fixed BJ/hTERT
cells. Cells were stained with Rif 1 1025 (green), G M 1 3 0 (red) and DAPI. This
localization is only observed by using Rifl 1025 antibody.
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at the Golgi complex (Figure 1-1 IB). The possible role of Rifl at both the mid-body and
Golgi apparatus is currently unknown. The single dot pattern was not suppressed in cells
treated with Rifl siRNA. Whether the Golgi pattern disappears after Rifl siRNA
treatment was not determined.
Dual IF with markers for telomeric sites, including TRFI, TRF2, and Rapl,
failed to reveal accumulation of Rifl on chromosome ends (Figure 1-5 and Chapter 2).
This failure of Rifl to co-localize with telomeres occurs in HeLa, IMR90, and BJ cells.
Negative results were also obtained using different methods for cell fixation
(paraformaldehyde and methanol) or extraction of soluble nucleoplasm^ proteins with
Triton X-100. Co-immunoprecipitation (co-IP) experiments were performed in order to
determine if hRifl interacts with known telomere proteins. Co-IP failed to find an
association of Rifl with TRFI, TRF2, and Rapl in HeLal.2.11 cells. Antibodies against
Rifl are able to successfully immunoprecipitate Rifl from HeLal.2.11 whole cell
extracts (Figure 1-12B). TRFI, TRF2 and Rapl are not detected in Rifl
immunoprecipitates (Figure 1-12A, E, and F). Conversely, Rifl is not detectable in
TRFI and TRF2 immunoprecipitates (Figre 1-12B). There is a small amount of Rifl in
the Rapl immunoprecipitate shown, but this is not reproducible in other experiments
(Figure 1-12B). The telomere complexes behaved as expected. As a positive control,
TRF2 and Rapl interact in this co-IP experiment (Figure 1-12A and E). Neither Rapl
nor TRF2 interact with TRFI in this experiment (Figure 1-12A,E, and F).
Co-IP was also used to determine whether or not Rifl interacts with components
of the Mrell complex. Using co-IP of endogenous complexes, Nbsl is detected in
Mrell immunoprecipitate as expected (Figure 1-12C and D). In this experiment, the
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Mrell immunoprecipitate contains detectable levels of Rifl (Figure 1-12B).

Rifl

immunoprecipitates contain no more Mre 11 than the beads alone control and only a small
amount of additional Nbsl (Figure 1-12C and D). It is unclear if these results indicate a
true biochemical interaction between Rifl and the Mre 11 complex. It is likely that either
the Mrell antibody used cross-reacts with additional proteins or that only a small
percentage of the Mre 11 complex is engaged in a complex with Rifl.
Chromatin immunoprecipitations (ChIP) with Rifl antiserum did not bring down
telomeric DNA (data not shown; experiment performed by Jill Donigian with technical
assistance from Diego Loayza). In this experiment, TRFI, TRF2, and Tin2
immunoprecipitates contained telomeric chromatin. These findings do not exclude a

possible association of a minor fraction of Rifl with telomeric sites or association of Rif
with telomeres in specialized cells or in response to specific stimuli.
Interestingly, Rifl associated with unusual telomeric loci present in certain ALT
cell lines. As discussed in the introduction, these structures are referred to as ALT
associated PML Bodies, or APBs. IF analysis showed that Rifl associated with APBs in
the ALT cell line GM847 (Figure 1-13). Rifl co-localizes with APBs in only about 20%
of cells and only a fraction of APBs contain Rifl within many cells. This may indicate
that APBs resemble DNA damage foci or that the telomeric DNA in the APBs represent a
rare state of the telomeric complex in which Rifl contributes to telomere function.
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Figure 1-12. Co-immunoprecipitation of h u m a n Rifl and known telomeric proteins.
Buffer C extracts were prepared from HeLai.2.11 cells and antibodies against Rifl
(1060), Rapl (765), T R F I (371) and T R F 2 (647), Mrell (874) and Nbsl (16/9, gift of
John Petrini) were used to immunoprecipitate endogenous complexes. Pellets were
washed and Laemelli buffer was added. The indicated IP pellets were immunoblotted
with antibodies against Rapl, Rifl, Mrel 1, Nbsl, T R F 2 and TRFI (A-F, respectively).
1 % of the input whole cell extract and a sample pellet with no IP antibody (beads alone)
were also immunoblotted. The lower bands in the immunoprecipitate lanes in Rapl and
T R F I immunoblots represent the IgG band of the immunoprecipitating antibodies.
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Figure 1-13. Rifl is found at APBs in A L T cells.
IF of Rifl (1060) with TRF2 (monoclonal anti-TRF2) on APBs in the A L T cell line
GM847.
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Discusssion

This chapter discusses the identification and initial characterization of human
Rifl, an ortholog of Rifl in yeast. Orthologs are genes that have primary sequence
similarity between two organisms, whereas homologs have primary sequence similarity
and the same function. We classify human Rifl as an ortholog rather than a homolog
because Rifl plays a role in telomere biology in yeast and a role in the DNA damage
response in human cells. Further work may establish that yeast and human Rifl are
homologs. Antibodies were raised against this large molecular weight protein in order to
address whether or not human Rifl is found at human telomeres. IF studies, coimmunoprecipitation experiments, and ChIP failed to detect an accumulation of Rifl at
telomeres, an interaction with telomeric proteins, or an association with telomeric
chromatin, respectively. The failure to detect Rifl at human telomeres under the
conditions tested does not conclusively rule out a possible role for Rifl at human
telomeres. Rifl can be found at APBs, although this is no guarantee that hRifl localizes
to human telomeres because APBs may contain other factors not normally found at
telomeres such as Rad52 (Yeager et al. 1999).
There are both possible technical reasons and biological reasons that these
experiments may represent a false negative result for Rifl at telomeres. Technical
limitations involve the ability of antibodies to recognize a potentially small amount of
telomeric Rifl and possibly weak or transient interactions between Rifl and telomeric
protein complexes. A number of biological factors may contribute to an inability to
localize Rifl to the telomere in human cells. First, Rifl may not be constuitively at
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telomeres and may require a signal or some other condition to localize to telomeres.
There is a precedent for the inability to detect Rifl at telomeres even when it is clearly
telomeric. The primary IF data in 5. pombe reveals that spRifl only co-localizes with
Tazl in strains lacking spRapl; wild type strains display a diffuse nucleoplasmic staining
for tagged spRifl (Kanoh and Ishikawa 2001). However, spRifl accumulates at
telomeric chromatin (Kanoh and Ishikawa 2001). Thus, further work is needed to
address the issue of whether Rifl is at telomeres. A complete data set would include an
analysis of telomere length when levels of human Rifl are perturbed and studying cells
expressing altered alleles of human Rifl. The human situation may also resemble the
situation in S. pombe where a component of the telomeric complex, such as Rapl, must
be deleted or altered before Rifl is detected at telomeres.
Rifl was also found at a variety of other sites in the cell and the exact role of
Rifl at these sites remains unclear. The cell-cycle nuclear dot pattern is a complete
mystery. The localization of Rifl at the Golgi apparatus is likely to be an artifact as it
only detected with the 1025 antibody and no others. The finding of Rifl at the mid-body
is more robust, seen with multiple antibodies, and may well represent a physiologic role

for Rifl in the execution of mitosis. It is possible that mice lacking Rifl will demonstrat
phenotypes related to these other cellular localizations for Rifl.
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C h a p t e r 2 - T h e role o f h u m a n
in the D N A

d a m a g e
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Rifl

response

Introduction

Evidence in yeast telomere biology suggests that Rifl is in a common pathway
with TEL1 and MEC1, orthologs of mammalian ATM and ATR. Rifl, Tell and Mecl
play important roles in telomere length regulation in both S. cerevisiae and 5. pombe. As
mentioned previously, yeast strains deficient in Rifl have elongated telomeres (Hardy et
al. 1992). Rifl is in the telomerase epistasis group in terms of telomere length regulation
with the other two groups being the Ku/Mrell/Xrs2/Rad50 group and the Cdcl3 group
(Nugent et al. 1998). Mutations in S. cerevisiae TEL1, the ATM ortholog, result in
telomere shortening (Greenwell et al. 1995). Deletion of S. cerevisiae MEC1 and its
ortholog S. pombe Rad3 leads to telomere shortening as well (Dahlen et al. 1998; Naito et
al. 1998; Ritchie et al. 1999). Tell and Mrel 1, Xrs2, and Rad50 are in the same telomere
length epistasis group (Ritchie and Petes 2000). Like ATM and ATR, Tell and Mecl
possess kinase activity and mutations in Tell and Mecl that abolish kinase activity result
in phenotypes identical to TEL1 and MEC1 deletion (Mallory and Petes 2000).
The combination of loss of TEL1 and MEC1 in S. cerevisiae or tell+ and rad3+ in

5. pombe results in disastrous consequences for yeast cells (Naito et al. 1998; Ritchie and
Petes 2000). tell-A mecl-A cells undergo telomere loss and senescence. Deletion of
both tell and rad3 in 5. pombe leads to the loss of all telomeric DNA and tell" rad3 cells
survive by circularizing their chromosomes (Naito et al. 1998). S. cerevisiae tell mecl
cells can not circularize their chromosomes and undergo a senescence phenotype similar
to the loss of telomerase (Ritchie et al. 1999). Thus, S. pombe cells survive only because
they are able to circularize their chromosomes after the loss of telomeric DNA. Strains
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lacking T E L 1 and M E C 1 senesce later than tell mecl tlcl strains and strains deleted for
tell and mecl still have telomerase activity in vitro, suggesting that Tell and Mecl do
not act by changing telomerase activity (Chan et al. 2001).
Studies of telomeres with X subtelomeric repeats and Y' subtelomeric repeats
initially demonstrated that the telomere length regulation of Rifl is affected by Tell
(Craven and Petes 1999). Rifl deletion is able to bypass the senescence phenotype of
tell mecl cells because tell mecl cells undergo senescence, yet tell mecl rifl yeast are
able to survive (Chan et al. 2001). Thus, the deletion of Rifl enables tell mecl cells to
bypass senescence, which suggests that Rifl may function in the same pathway as Tell
and Mecl. Additionally, rifl rif2 cells have long, heterogeneous telomeres, whereas tell
mecl smll rifl rif2 (the SML1 deletion is necessary to maintain viable cells in a MEC1
delete strain) do not have heterogeneous telomeres (Chan et al. 2001). The epistatic
relationship and underlying mechanism between TEL1 and RIF1 is unclear. Because of
this link in yeast, we examined the possible relationship between Rifl and ATM and
ATR in human cells.
This chapter documents the unexpected discovery that human Rifl is involved in
the DNA damage response. The characteristics of Rifl ionizing radiation induced foci
(IRIF), such as the rapid kinetics of formation and dose response are discussed. Rifl
IRIF co-localize with a number of other previously identified DNA damage response
proteins, specifically ATM, BRCA1, Chkl, y-H2AX, 53BP1 and the Mrell complex.
Furthermore, Rifl localized to uncapped telomeres, as do other DNA damage response
factors. Whereas inhibition of ATR signaling did not inhibit the Rifl response, ATM
deficient cells treated with IR or UV lacked Rifl foci even after prolonged incubation or
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high radiation dose. The Rifl response also depended on the presence of 53BP1 but was
not affected by reduced function of BRCA1, Chk2, Nbsl, and Mrell. RNAi-mediated
Rifl inhibition resulted in increased radiosensitivity, indicating that Rifl function
contributes to the ATM-mediated protection against exposure to ionizing radiation.

Results

In cells treated with IR, the Rifl IF signal became redistributed into discrete foci
that were detectable with all Rifl antibodies (Figure 2-1). This response was rapid,
occurring within 5 min, and persisted for many hours (Fig. 2-1C). All cells of an
asynchronous population showed the same or a similar response indicating that Rifl can
relocalize in Gl, S, and G2 cells. Rifl foci were observed after an IR dose as low as 0.5
Gy and the number of foci increased with higher doses, reaching a plateau between 10
and 20 Gy (Fig. 2-1 A). Rifl ionizing-radiation-induced foci (IRIF) exhibit similar
behavior, such as a distribution in number of IRIF per cell, a dose-response relationship
in average number of foci, and changes in foci number and size over time, to previously
described DNA damage response factors such as Mrell and 53BP1 (Schultz et al. 2000;
Mirzoeva and Petrini 2001). IRIF were observed in BJ cells using the four antibodies
1025, 1060, 1066, and 1067 that recognize human Rifl (Figure 2-2).
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Figure 2-1. H u m a n Rifl forms foci in cells exposed to ionizing radiation.
A. Rifl foci after IR treatment. Rifl IF (Ab 1060) of I M R 9 0 primaryfibroblasts(pi7),
exposed to the indicated levels of IR andfixedafter 30 min.
B. Co-localization of Rifl with 53BP1. IF of DVIR90 (pl5) cells, exposed to 5 G y IR and
fixed 2 hr post-IR. Cells were then stained with Rifl (green) and 53BP1 (red) antibodies
for IF.
C. Time course of the Rifl response. IF as in A. but after 5 G y IR and with fixation at
the indicated time points.
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IR-induced foci were observed in a wide range of cell lines examined, including IMR90,
BJ, HeLa, and U20S cells (Figure 2-1, 2-2, 2-10B and 2-12B). The IR-induced Rifl foci
showed a complete co-localization with the DNA damage response factor 53BP1
(Anderson et al. 2001; DiTullio et al. 2002; Wang et al. 2002) (Fig. 2-IB and see below),
consistent with the idea that Rifl re-localizes to sites of DNA damage. Rifl does not

form these foci or co-localize with 53BP1 in cells not exposed to radiation (Figure 2-2, 23, 2-4 and 2-7A). IR-induced foci did not co-localize with the known telomeric proteins
TRFI, TRF2, and Rapl (Figure 2-3).
Rifl also formed foci after treatment of cells with MMS or etoposide and the
Rifl foci in these cells co-localized with 53BP1 foci (Figure 2-4A). UV treatment
resulted in the formation of Rifl foci which co-localized with 53BP1 foci (Figure 2-4B).
UV treatment induced a Rifl response in a subset of the cells (~20-30%) whereas IRinduced Rifl foci occurred in all interphase cells (Figure 2-1 and 2-4C). Furthermore, the
UV-induced Rifl foci were slow to develop compared with IR-induced Rifl foci. The
UV-induced foci first appear 1 hr after UV exposure (Figure 2-4B). This time frame is
markedly different from the rapid response after IR. A possible explanation for the
occurrence of foci in only a subset of cells treated with UV as well as the delay in Rifl
response to UV is that the primary UV-induced lesions are converted into doublestranded breaks (DSBs) during S phase and that Rifl actually responds to these DSBs.
In addition to 53BP1, the Rifl foci contained several other DNA damage
response factors, including y-H2AX, Chkl phosphorylated on S317, ATM
phosphorylated on SI981, Rad 17 phosphorylated on S645, Mrel 1, and BRCA1 (Figure
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Figure 2-2. Multiple Rifl antibodies recognize Rifl IRIF.
BJ primaryfibroblastswerefixed2 hr after exposure to 5 G y IR. Cells were stained with
Rifl (antibody 1025 in A., antibody 1060 in B., antibody 1066 in C , and antibody 1067
in D.). In A. and B., cells were also stained with 53BP1 antibodies (red). In C. and D.,
cells were also treated with D A P I (blue).
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Figure 2-3. Rifl IRIF do not co-localize with h u m a n telomeres.
A. HeLal.2.11 cells were either untreated or exposed to 5 G y IR and fixed 30 minutes
post-IR. Cells were then stained with Rifl (green), TRFI (red) and D A P I (blue).
B. HeLal.2.11 cells were either untreated or exposed to 5 G y IR and fixed 30 minutes
post-IR. Cells were then stained with Rifl (green), T R F 2 (red) and D A P I (blue).
C. HeLal.2.11 cells were either untreated or exposed to 5 G y IR and fixed 30 minutes
post-IR. Cells were then stained with Rifl (green), Rapl (red) and D A P I (blue).
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Figure 2-4.

Rifl forms foci following exposure to clastogenic drugs and

UV

treatment.
A. Rifl foci in response to M M S , etoposide and hydroxyurea treatment. I M R 9 0 (PI5)
cells were treated for 1 hr with 0.01% M M S , 50 mg/ml etoposide, or no drug prior to
fixation. For H U treatment, I M R 9 0 (p26) cells were incubated for 18 hr with 2 m M
hydroxyurea prior tofixation.Rifl and 53BP1 were detected as in Figure IB.
B. Response of Rifl to U V irradiation. I M R 9 0 (P14) cells were exposed to U V light (25
J/m2),fixedat the indicated time points, and processed for Rifl and 53BP1 IF as in A.
C. A subset of cells responds to U V irradiation. I M R 9 0 (P14) cells were exposed to U V
light (25 J/m2), fixed 1 hr post-UV. and stained with Rifl antibody (green), 53BP1
antibody (red) and D A P I (blue).
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2-5). A s a control, Rifl IR-induced foci do not co-localize with the telomere proteins
TRFI, TRF2, and Rapl (Figure 2-3A-C). It has previously been shown that y-H2AX,
ATM phosphorylated on SI981, 53BP1, Rad 17 phosphorylated on S645 and the Mrell
complex do not co-localize with telomeric proteins (Zhu et al. 2000; Takai et al. 2003).
Rifl behaves similarly to previously described factors that respond to the formation of
double strand DNA breaks.
Work in the de Lange lab has previously shown that dysfunctional telomeres are
recognized as sites of DNA damage (Takai et al. 2003). Cells have the ability to
distinguish functional telomeres from DNA breaks and this distinction is made based on
the presence of a specific telomeric protein complex (de Lange 2002). The main
protective protein at telomeres is TRF2. Inhibition of TRF2 with a dominant negative
allele or siRNA results in telomere uncapping. Such uncapped telomeres induce a cell
cycle arrest and are processed by DNA damage repair pathways, including the NHEJ
pathway which generates chromosome end fusions. Furthermore, uncapped telomeres
activate the ATM-dependent DNA damage response (Takai et al. 2003). As a
consequence, telomeres become associated with DNA damage response factors, such as
Nbsl, 53BP1, ATM, Radl7, and y-H2AX (Takai et al. 2003). The foci formed at
uncapped telomeres resemble DNA damage response foci and are referred to as Telomere
Dysfunction Induced Foci (TIFs). To test whether Rifl is a component of the TIFs
formed at uncapped, dysfunctional telomeres, IF was done in BJ/hTERT cells that were
infected with an adenovirus expressing the dominant negative allele of TRF2 (AdTRF2ABAM; (Karlseder et al. 1999)). Co-staining with an antibody to TRFI was used to
determine whether Rifl binds to the telomeric sites.
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Figure 2-5. Rifl IRIF co-localize with other known D N A damage response proteins.
I M R 9 0 cells were treated with 5 G y IR andfixedwith paraformaldehyde 1 hr later. Cells
were then co-stained for Rifl (rabbit 1060, green) and B R C A 1 (red) or Rifl (mouse
1060, green) and ATM-S1981-P, Chkl-S317-P, g-H2AX, Radl7-S645-P and Nbsl (red)
as indicated. The merged images include D A P I stain (blue). For co-staining of Rifl and
Nbsl, cells were treated with cytoskeleton extraction buffer andfixedas in (Mirzoeva
and Petrini 2001).
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Comparison of cells infected with a control adenovirus and cells in which T R F 2 was
inhibited using Ad-TRF2ABAM showed that Rifl formed foci on uncapped telomeres
(Figure 2-6; experiment performed by Hiroyuki Takai). Thus, also in this regard, Rifl
behaves as other DNA damage response factors, many of which have no known role in
normal telomere function.
The induction of Rifl foci was severely reduced when cells were treated with
inhibitors of the PI3 kinase-related family of kinases (PIKKs), which includes ATM and
ATR. The central role of the ATM and ATR in the DNA damage response makes the
dependence of Rifl IRIF on ATM and ATR signaling an important question. The drugs
caffeine and wortmannin were used in order to initially address whether Rifl is
dependent on PIKK family members in terms of foci formation. Treatment with caffeine
and wortmannin almost completely abolished the Rifl response to IR (Figure 2-7A and
2-7B). The effect of caffeine on Rifl was more pronounced than its effect on 53BP1
(Figure 2-7A), suggesting that Rifl is exquisitely sensitive to signaling by one or more
PIKKs.
In order to test the dependence of Rifl on the ATM kinase, we examined the
response of Rifl to IR and UV in cells derived from A-T patients. Two unrelated A-T
fibroblast strains, AG02496 and AG04405, lacked the ATM kinase as verified by
immunoblotting (Takai et al. 2003). These A-T cells failed to show Rifl foci when
examined 2 hr after 5 Gy (Figure 2-8A). Rifl foci were also not observed after treatment
with 20 Gy and at later time-points (up to 8 hr) (Figure 2-8A). By contrast, the A-T cells
formed 53BP1 foci after IR (Figure 2-8A), albeit at diminished levels as previously noted

98

(Rappold et al. 2001). The A-T cells contained normal amounts of Rifl proteins as
detected by immunoblotting (Figure 2-8B). Although the figure depicts elevated Rifl in
cells exposed to 20 Gy, this is not reproducible.
Human Rifl contains 11 ST and 13 QT sites that could potentially be a direct
target of the ATM kinase, but direct evidence for the phosphorylation of Rifl by ATM is
not available at this stage. A number of DNA damage response proteins, including the
large molecular weight proteins BRCA1, MDC1 and 53BP1, shift upward in
immunoblots after being phosphorylated by ATM or ATR (Cortez et al. 1999; Goldberg

et al. 2003; Lou et al. 2003a; Stewart et al. 2003). Rifl does not have a detectable shift i
immunoblots 4 hours after cells are exposed to 20 Gy IR (Figure 2-9). The blot shown
contains varying amounts of Rifl in the lanes, making interpretation difficult. In other
experiments, the amount of Rifl is equal between untreated and irradiated cells and no

shift is detected. It is important to note that a lack of Rifl shift in immunoblot followin
radiation exposure is not conclusive evidence that Rifl is not phosphorylated by ATM.
In vitro phosphorylation assays are underway to determine if Rifl is directly
phosphorylated by ATM.
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Figure 2-6. Rifl localizes to dysfunctional telomeres.
hTERT-BJ cells were infected with the indicated adenoviruses (control: b-galactosidase
virus)fixed48-52 hr post-infection and processed for Rifl (mouse anti-1060, green) and
T R F I (Ab 371; red) IF as described in (Takai et al. 2003). D N A was stained (DAPI,
blue) in the merged images. White arrows highlight a subset of the Rifl foci at telomeres.
The enlarged images are derived from the same experiment. This experiment was
conducted by Hiroyuki Takai.
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Figure 2-7. The P I K K inhibitors caffeine and wortmannin inhibit Rifl IRIF
formation.
A. Effect of caffeine on Rifl foci. I M R 9 0 (P14) cells were treated with 20 m M caffeine
2 hr prior to 1 G y IR andfixed30 min post-IR. IF for Rifl and 53BP1 as in Figure IB.
B. Effect of wortmannin on Rifl foci. I M R 9 0 (P29) cells were treated with 100 m M
wortmannin 1 hr prior to 5 G y IR,fixed30 min post-IR, and processed for IF as in A.
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Figure 2-8. Absence of Rifl foci in A-T cells.
A. A-T fibroblasts (AG02496 and AG04405) which lack the A T M kinase were exposed
to either 5 G y IR or 25 J/m2 U V . Cells werefixed2 hr or 8 hr after IR and 6 hr after U V
and processed for IF as in Figure IB.
B. A-Tfibroblasts(AG04405) were exposed to IR as indicated and whole cell lysates
were prepared 1 hr post-IR. Immunoblotting was performed using Rifl and tubulin
antibodies.
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Since Rifl forms foci after treatment with U V , which is thought to activate the
ATR kinase, we tested whether Rifl depends on both ATR and ATM, as is the case for
numerous other DNA damage response factors. ATR signaling can be inhibited using
siRNAs against ATRIP, an essential partner for ATR (Cortez et al. 2001). As previously
shown, two different ATRIP siRNAs resulted in strong reduction of the ATRIP protein
(Figure 2-10A). These siRNAs did not affect Rifl protein levels (Figure 2-10A).
Despite the reduction in ATRIP protein levels, UV treatment continued to induce Rifl
foci in these cells (Figure 2-10B). Therefore, we tested whether the Rifl foci formed
after UV treatment were dependent of ATM signaling. No Rifl foci were formed upon
UV treatment of A-T cells (Figure 2-8A), even though the cells formed 53BP1 foci.
Thus, Rifl appears to depend exclusively on ATM rather than ATR for its response to
DNA damage, even when the damage is a consequence of UV treatment.
Several components of the ATM signaling pathway were tested for their role in
Rifl regulation. Although Chk2 is a downstream target of ATM (Matsuoka et al. 1998),
its activity was not required for Rifl regulation; Chk2-deficient HCT15 cells still
displayed Rifl foci after IR (Figure 2-11 A). Furthermore, we tested the role of the
Mrel 1 complex, which has been shown to contribute to the ATM pathway both upstream
and downstream of ATM ((Carney et al. 1998; Lim et al. 2000); reviewed in (Petrini and
Stracker 2003)). LB1 cells derived from a Nijmegen breakage syndrome patient with a
hypomorphic mutation in the Nbsl component of the Mrell complex, specifically a
657del5 mutations in NBS1, did not display an obvious defect in Rifl focus formation
(Zdzienicka 1999) (Figure 2-1 IB). Similarly, two Mrell mutant cell lines (ATLD3 and
4; (Stewart et al. 1999)) formed Rifl foci after IR (Figure 2-1 IC). ATLD3 and ATLD4
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U 2 0 S cells were pretreated with 100 m m wortmannin as indicated 1 hr prior to IR
exposure of 0, 10, or 20 G y IR as indicated. Whole cell lysates were prepared at
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thefirsttransfection for expression of the indicated proteins. Rifl was detected with
mouse serum 1060.
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Figure 2-11. Deficiency of Chk2, Nbsl, Mrell or Nbsl does not affect Rifl IRIF.
A. Effect of Chk2 deficiency on response of Rifl to IR. Chk2 deficient HCT15 cells. For
panels A-D, cells were treated with 5 Gy and processed for Rifl and 53BP1 IF after 1 hr
as in Figure IB.
B. Effect of Nbsl deficiency on response of Rifl to IR. SV40-transformed NBS1-LB1
cells.
C. Effect of Mrel 1 deficiency on response of Rifl to IR. Mrel 1 mutated ATLD4 cells.
D. Effect of BRCA1 deficiency on response of Rifl to IR. BRCA1 deficient HCC1937
cells.
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Figure 2-12. Rifl IR-induced foci are dependent on 53BP1.
A. Immunoblotting analysis of the effect of 53BP1 siRNAs. HeLa cells were transfected
twice with the indicated siRNAs and analyzed by immunoblotting 72 hr after the first
transfection for expression of the indicated proteins. Rifl was detected with mouse 1060.
B. Rifl foci formation upon IR in cells treated with 53BP1 siRNA. Cells were exposed
to 5 G y IR 72 hr after mock transfection or transfection with either control (GFP) or
53BP1 siRNA olgionucleotides. Cells werefixed1 hr after exposure and processed for
IF as in Figure IB.
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cell lines are primary fibroblasts derived from siblings that carry an A to G missense
mutation at nt 350 that results in an N -^ S amino acid change (Stewart et al. 1999).
Finally, HCC1937 cells deficient for the ATM target BRCA1 retained the ability to form
Rifl foci (Tomlinson et al. 1998) (Figure 2-1 ID). HCC1937 cells produce a truncated
disease-producing mutant allele (5382insertC) and no wild type protein (Chen et al. 1998;
Tomlinson et al. 1998).
In contrast, inhibition of 53BP1 completely abolished the Rifl DNA damage
response. Reduction in 53BP1 expression was achieved with two different siRNAs as
demonstrated by Western analysis ((Wang et al. 2002); Figure 2-12A). Rifl protein
expression was not affected by these siRNAs (Figure 2-12A). As expected, the induction
of 53BP1 foci by IR was strongly reduced in cells treated with the 53BP1 siRNAs
(Figure 2-12B). Cells without 53BP1 foci also lacked Rifl foci indicating a Rifl depends
on 53BP1 for its localization to damage foci. Normal Rifl foci occurred in the few cells
that had escaped the effects of the 53BP1 siRNAs, providing an internal control in the
experiments (Figure 2-12B). The repression of Rifl foci with two independent 53BP1
siRNAs argues against off-target siRNA effects, namely the suppression of mRNA and
protein levels of other genes by a given siRNA sequence. Off target effects are
minimized by obtaining similar results with multiple siRNAs and by checking that
siRNA target sequences are unique within the genome. Furthermore, the Rifl response
was not affected by several other siRNAs (GFP, BRCA1, ATRIP, and luciferase; Figures
2-10A and 2-12A), demonstrating the specificity of the 53BP1 siRNA effect. Thus, Rifl
appears to be regulated by two components of the ATM pathway, 53BP1 and ATM itself.
Since 53BP1 forms foci in A- T cells but Rifl does not (Figure 2-8A), it appears that Rifl
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requires an A T M regulated event in addition to 53BP1 foci formation. This implies that
at least two independent molecular events, one ATM-dependent and the other 53BP1dependent are required for the recruitment of Rifl to sites of DNA damage. It is
currently unclear whether or not ATM acts to directly phosphorylate Rifl. As mentioned
previously, Rifl does not shift in immunoblots after radiation (Figure 2-9). As
mentioned previously, in vitro kinase assays to address whether ATM directly
phosphorylates Rifl are being performed.
RNAi was used to study the consequences of diminished Rifl functions. We
created 8 independent sets of siRNA oligonucleotides to Rifl (Chapter 1). The siRNA
nucleotides were designed through inspection of the Rifl sequence (using the guidelines
set forth in (Elbashir et al. 2001)). Additionally, a goal was to design siRNA
oligonucleotides that were distributed throughout the predicted Rifl open reading frame.
Six of these eight siRNAs strongly reduced Rifl protein levels and the other two siRNAs
led to a 50% decrease in Rifl protein levels (Figure 2-13A). The siRNAs also interfered
with the formation of Rifl foci after ionizing radiation (Figure 2-13B). siRNA transient
transfection affects approximately 90% of cells. The untranfected cells shown in the

bottom right panel of Figure 2-13B) still display foci formation after radiation and act as
an internal positive control. As mentioned above, control siRNAs do not have this effect,
demonstrating the specificity of the Rifl siRNAs. Temporary knock-down of Rifl
expression with siRNA did not affect cell viability or long term growth. This is
demonstrated by the ability of Rifl siRNA treated cells to form similar numbers of
colonies as control cells in a colony formation assay without radiation (Figure 2-16B).
Furthermore, in keeping with the lack of obvious association of Rifl with telomeres, Rifl
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siRNA treatment did not have an acute effect on telomere function. For instance, the
telomeric DNA remained intact and telomere fusions, which are indicative of telomere
uncapping, were not induced (Figure 2-14). In fact, metaphase spreads in Rifl siRNA
treated cells did not appear to be abnormal or different from control treated metaphase
spreads (Figure 2-14).
As Rifl is a component of the ATM pathway, we examined the effect of Rifl
siRNAs on several aspects of ATM signaling. The activating auto-phosphorylation of
ATM at serine 1981 was not affected by Rifl siRNA treatment and the phosphorylation
of Nbsl, Chkl, BRCA1, and p53 on ATM target sites occurred normally in irradiated
cells with reduced Rifl (Figure 2-15A). This demonstrates that Rifl siRNA treatment
does not affect the ability of ATM to phosphorylate these targets. Furthermore, Rifl
inhibition did not affect IR-induced focus formation by 53BP1 (Figure 2-13C), showing
that Rifl is downstream of 53BP1 in terms of focus formation.
Exposure of cells to IR leads to the accumulation of p53, transcriptional
activation of p21, and subsequently the induction of a Gl/S cell cycle arrest. U20S cells
treated with Rifl siRNAs had a comparable level of p21 induction to Mock, GFP and
53BP1 treated cells (Figure 2-15B).
Although ATM signaling was not strongly affected, treatment of HeLa cells with
two different Rifl siRNAs resulted in decreased clonogenic survival after ionizing
radiation (Figure 2-16A). Control cultures were either mock treated or treated with an
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Figure 2-13. Rifl siRNA.
A. Immunoblotting analysis of Rifl siRNAs. HeLa cells were transfected twice with the
indicated siRNAs and analyzed by immunoblotting 72 hr after thefirsttransfection for
expression of the indicated proteins. Rifl was detected with A b 1060.
B. Rifl siRNA abrogates Rifl ionizing radiation-induced foci. Rifl siRNA treatment as
in (A). Cells werefixed1 hr after IR. IF for Rifl (green) was performed using antibody
1060.
C. IR-induced 53BP1 foci in cells treated with Rifl siRNA. U 2 0 S cells were exposed to
5 G y IR 72 hr after mock transfection or transfection with Rifl siRNA #2. Cells were
fixed 1 hr post-IR and processed for 53 BP1 IF. D N A is stained with DAPI.
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Figure 2-14. Metaphase spreads of cells treated with Rifl siRNA.
HeLal.2.11 cells were transfected twice with the indicated siRNAs and metaphase
spreads were prepared 72 hr after thefirsttransfection. Metaphase spreads were stained
with D A P I (blue).
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Figure 2-15. ATM-dependent phosphorylation of targets and p53 IR response in
cells treated with Rifl siRNAs.
A. U 2 0 S cells were transfected twice with the indicated siRNAs and treated with either
0 G y or 10 G y IR 72 hr after the first transfection. Whole cells lysates were then prepared
1 hr after IR exposure. Immunoblotting of these lysates was performed using mouse
1060 antisera and antibodies recognizing ATM-S1981-P, BRCA1-S1524-P, Chkl-S317P, p53-Serl5-P and Nbsl-S343-P. Anti-tubulin blotting was used as a loading control.
B. U 2 0 S cells were transfected twice with the indicated siRNAs and treated with either
0 G y or 10 G y IR 72 hr after thefirsttransfection. Whole cells lysates were then prepared
at 0, 1, 2, or 4 hr after IR exposure as indicated. Immunoblotting of these lysates was
performed using mouse 1060 antisera and antibodies recognizing p53 and p21. Antitubulin blotting was used as a loading control.
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Figure 2-16. Cells deficient in Rifl are radiosensitive.
A . Effect on Rifl s i R N A on clonogenic survival after IR. Cells treated with s i R N A as
indicated were brought to the same concentration and irradiated with the indicated dose
of IR 72 hr after transfection and plated in triplicate at multiple concentrations.
C o m m a s s i e stained colonies were counted after 14 days using dilutions resulting in
similar colony numbers for the various treatments. Error bars indicate standard deviation
within triplicate plating for each experiment. Dashed lines indicate the least squared
linear regression through either m o c k and Scrambled I (black) or two independent Rifl
siRNAs (#2 and #4) (red) data points.
B. Clonogenic survival assay. Cells treated, plated and stained as in A. Photograph of
coomassie stained sample plates (IO4 cells plated per 6 cm2 dish) from m o c k and Rifl set
# 2 s i R N A treated cells.
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irrelevant control siRNA. Reduction in Rifl reproducibly resulted in a 5 0 % increase in
the radiosensitivity (Figure 2-16A). After radiation with 6 Gy, Rifl knockdown cells
showed a 4.3-fold less clonogenic survival (P < 0.0001, students t test). This effect is
comparable to the radiosensitivity due to knockdown of BRCA1 with siRNA (Ganesan et
al. 2002) (data not shown), but modest compared to the radiosensitivity of A-T cells
which typically show 10-fold lower survival rates. The RNAi experiments may
underestimate the importance of Rifl for survival after DNA damage as siRNA effects
are incomplete and short-lived.
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Discussion
Rifl is a bona fide member of the DNA damage response in human cells. Rifl
forms IRIF and co-localizes with other DNA damage components. Rifl critically
depends on both ATM and 53BP1 for its localization to sites of damage after IR. The
radiosensitivity of cells deficient in Rifl confirms that Rifl plays a biologically

significant role in the cellular response to IR. These results were quite surprising given
the role of Rifl in yeast telomere biology. The observation that rif 1-A yeast strains
display significantly elevated rates of chromosome loss suggests that Rifl may play a
role in the maintenance of genomic stability and DNA damage response in yeast (Wotton
and Shore 1997). However, rifl-A yeast do not have a GCR phenotype (Myung et al.
2001). As mentioned, RIF1 deletion also allows tell mecl strains to bypass senescence,
which suggests that ATM and Rifl are in a common pathway in telomere maintenance.
It appears that this pathway extends to the DNA damage response in mammalian cells.
The elucidation of more details about the role of Rifl in the DNA damage
response could provide light as to the exact function of Rifl in the DNA damage

response. One of the basic issues that remains is the determination of whether or not Rifl
is phosphorylated directly by ATM (and/or other kinases) in response to IR and the
location(s) of these phosphorylation sites. This would allow one to test the consequences
of re-introducing Rifl with mutated phosphorylation sites back into cells. Another
important piece of work that would aid in the understanding of Rifl is the cloning of the
full-length Rifl cDNA to determine which domains are responsible for recruitment to
sites of damage and hypersensitivity phenotype. Finally, the limitations of the transient
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nature of the s i R N A transfections used to study Rifl could be overcome through either
the use of retroviruses that express shRNA hairpin oligonucleotides which allow for a
longer-term knockdown of Rifl. Questions such as a possible role of Rifl in telomere
length regulation and the issue of whether or not Rifl deficiency results in genomic
instability could be addressed this way.
A critical issue involves the molecular mechanism underlying the radiosensitivity
of Rifl. The possible mechanisms of hypersensitivity involve roles in ATM signaling,
one or more cell-cycle checkpoints, apoptosis and repair. The ability of ATM to
phosphorylate many of its targets remains intact in cells treated with Rifl siRNAs. This
suggests that ATM signaling remains intact in Rif 1-deficient cells, although there may
still be an as-of-yet unidentified target of ATM. It is still possible that Rifl could play a
role in either the Gl/S or intra-S-phase checkpoint. Radioresistance DNA synthesis
(RDS) assays should be performed on cells deficient in Rifl to assay the intra-S-phase
checkpoint. Rifl does not seem to affect IR-induced apoptosis as assayed by TUNEL.
Finally, a role for Rifl in DNA repair may explain the radiosensitivity of Rif 1-deficient
cells.
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screening

Introduction

The identification and characterization hRapl-interacting factors could
potentially answer a number of important questions in the field of telomere biology.
First, it could provide insight into the differences between mammalian and yeast
telomeric complexes in terms of both evolutionary considerations and mechanisms of
telomere length regulation. As mentioned in the introduction, Rapl binds directly to
telomeric DNA directly in S. cerevisiae, while it is recruited to telomeres through its
interaction with TRF2 in human cells and the TRF-like Tazlp in S. pombe. The
identification of additional protein components at telomeres could help shed light on the
evolution of the Rapl complex and explain the differences between these complexes in S.
cerevisiae, S. pombe and mammalian cells. The elucidation of Rapl-interacting factors
would also extend current knowledge regarding telomere length regulation in telomerasepositive mammalian cells. Presumably, other factors besides telomerase, TRFI, and
TRF2 function to regulate telomere length either via influencing the properties of t-loops
or via some other mechanism.
An understanding of the domain structure of hRapl is necessary in order to select
baits for yeast two-hybrid screens. The most obvious candidate for a protein interaction
domain is the C-terminal domain of Rapl, termed the RCT (Li et al. 2000). In S.

cerevisiae, this domain recruits Sir3, Sir4, Rifl and Rif2 (Hardy et al. 1992; Moretti et al
1994; Cockell et al. 1995; Liu and Lustig 1996; Wotton and Shore 1997). Additionally,
Rapl in S. cerevisiae contains an N-terminal BRCA1 C-terminal (BRCT) domain, which
is a domain known to be involved in protein-protein interactions (Bork et al. 1997;
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Callebaut and Mornon 1997). Both the R C T and B R C T domains are conserved in human
Rapl (Li et al. 2000). S. cerevisiae Rapl contains two Myb-type helix-turn-helix motifs,
which recognize two tandem GGTGT sites spaced 8 bp apart (Konig et al. 1996). This
domain has been crystallized bound to DNA and folds like two copies of the Myb protooncogene DNA binding domain (Konig et al. 1996). Human Rapl contains a single Myb
domain and is unable to directly bind to telomeric DNA (Li et al. 2000). TRFI and TRF2
each contain a single Myb domain, but both TRFI and TRF2 homodimerize in order to
be able to bind to telomeric DNA (Bianchi et al. 1997; Broccoli et al. 1997a; Bianchi et
al. 1999). Rapl has a transcriptional activation domain in S. cerevisiae, but this is not
conserved in human Rapl (Li et al. 2000). Finally, hRapl contains a coiled-coil region
which may be involved in protein-protein interactions. Thus, both the N-terminal BRCT
domain and the C-terminal RCT are reasonable candidates for regions of hRapl that
might interact with proteins. As described in this chapter, a bait consisting of the hRapl
C-terminus was used to perform a yeast two-hybrid screen. Recent data based on both
the localization of various Rapl alleles to telomeres and the telomere length phenotypes
of these alleles suggests that both the BRCT domain and the Myb domain of hRapl

recruit an as-of-yet unidentified factor that inhibits telomere elongation (Li and De Lange
2003).
This chapter describes the execution of a series of yeast two-hybrid screens in
order to screen for proteins that interact with hRapl. The positive clones in a screen
using the C-terminus of hRapl as a bait correspond to two genes, a novel zinc finger
protein referred to as C144, and a previously identified factor called FLASH which is
known to play a role in apoptosis. The full-length C144 was cloned and experiments
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were conducted to determine whether or not C 1 4 4 has a role in h u m a n telomere biology.
Co-immunoprecipitation and studies fail to show that C144 interacts with known
telomere proteins or that C144 localizes to telomeres. A yeast ortholog of C144 was
identified and yeast strains lacking this C144 ortholog do not experience changes in
telomere length over the course of 100 generations.

Results and discussion

A standard yeast two-hybrid screen was used in order to search for factors that
interact with hRap 1. An initial screen was carried out using an N-terminal LexA fused to
a full-length hRapl as bait to screen a human fetal liver cDNA library. The full-length
hRapl-LexA fusion bait was slightly toxic to cells as indicated by slow cell growth in
liquid culture and a delay in colony formation. This bait behaved as expected in terms of
yeast two-hybrid interaction, interacting with TRF2 but not TRFI (Li et al. 2000).
Analysis of several hundred colonies that grew on histidine-deficient plates out of the
initial 4 million transformants resulted in no true positive results for this initial screen.
Several criteria were used in order to verify that a colony growing on histidine dropout
plates is a true positive in the screen. First, colonies were restreaked on histidine dropout
plates to verify phenotype. Secondly, a filter lift assay was used to verify that the baitprey combination could turn on the P-galactosidase gene as well. Finally, the prey
plasmid DNA was then isolated, re-transformed into yeast and both nutritional and |3galactosidase phenotypes are tested to verify that the phenotype is plasmid-linked.
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A second screen was undertaken using the C-terminus of hRapl as a bait. The Cterminal bait consisted of LexA fused to amino aids 128-399 of hRapl. This bait
contains the myb domains, coiled-coil domain and RCT of hRapl and interacts with
hTRF2 in a yeast two-hybrid setting (Li et al. 2000). The C-terminus of scRapl was

chosen because it is the portion of the protein that interacts with Riflp, Rif2p, Sir3p, an
Sir4p. The background of this screen was high due to the ability of the C-terminal Rapl
bait to activate transcription. An inhibitor of His, 3-AT, was used in the third screen.
A third screen was executed using 3-AT and approximately 300 colonies grew on
selective plates out of approximately four million transformants. Further analysis
revealed approximately 120 positives in the screen that fell into 5 groups. These groups
were based on similar restriction digestion patterns after the prey plasmid DNA was
isolated. These clones met the re-screening criteria mentioned above. A quantitative Pgalactosidase assay was performed after verification that growth on histidine-deficient
plates and P-galactosidase activation were plasmid-linked (Figure 3-1).
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Figure 3-1. Quantitative p-galactosidase results for yeast two-hybrid screen.
A quantitative P-galactosidase liquid culture assay was performed on the indicated strains
of yeast. Results are given in standardize units. The formula for b-galactosidase units =
(1000 x O D 4 2 0 ) / (t x V x O D 6 0 0 ) where t = elapsed time in minutes of incubation and V
= 0.1 ml x concentration factor.
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The positive clones in the screen were sequenced and the resulting sequences
were entered as queries against the Genbank database using a standard BLAST
algorithm. The sequences corresponded to two genes. The first is a human gene with no
homology to known genes in the human genome. This gene, designated C144 because it
corresponds to clone 144 of the 300 initial colonies picked in the screen, is a novel
human gene containing a CCHC-type zinc finger domain. The second clone identified
was the previously identified human gene FLASH (Flice - Associated Huge) (Imai et al.
1999). This gene has no known role in human telomere biology. A number of proteins
that might be expected to appear in the screen did not appear amongst the clones. Neither
TRF2 nor hRapl (Rapl is capable of forming homodimers) were identified. This
suggested that the screen was not performed under saturating conditions or that TRF2 or
Rapl were somehow under-represented in the cDNA library used. Also, no obvious
homologs of Rifl, Rif2, Sir3, or Sir4 proteins were identified.
The yeast two-hybrid prey contained only a portion of the full-length C144. The
1.2 kb fragment of C144 in the prey plasmid was excised and used as a probe to screen a
human kidney cDNA library in order to determine the full-length sequence of C144. A
full-length clone containing a 1.6 kb predicted open reading frame (ORF) was isolated
and sequenced using standard cloning methods. The C144 ORF contains a 543 amino
acid protein with a predicted molecular weight of 65 kilodaltons (Figure 3-2). The
predicted starting ATG has an upstream sequence of CAAATCTTG which represents a
weak Kozak sequence. However, there is also an in-frame stop codon located 60 base
pairs upstream of the ATG in the full-length clone, which points to the predicted ATG as
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Figure 3-2. C144, a novel CCHC-type zinc finger protein.
A. A schematic diagram of C144. The CCHC zinc finger domain is shown in green.
B. The protein sequence of the full-length C144 gene.
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the correct one. The 1.2 kb yeast two-hybrid fragment contains the N-terminal portion of
C144 extending from amino acid 1 through amino acid 370.
The predicted C144 protein contains four CCHC-type zinc finger domains in the
central portion of the open reading frame (Figure 3-1 and 3-2). CCHC-type zinc finger
domains are a family of widely conserved domains that are able to bind a variety of
nucleic acid structures, including both ssDNA and dsDNA (Summers 1991). CCHC-type

zinc finger domains are also found in retroviral gag proteins and are thought to play a rol
in the binding of retroviral RNA genomes to the viral particle (Ramboarina et al. 1999).
Figure 3-2 depicts the alignment of the C144 CCHC-type zinc finger domains with
CCHC-type zinc finger domains in a variety of other organisms (Figure 3-3).
In order to study the possible role of C144 at telomeres and determine whether or
not C144 is a bona fide hRapl-interacting factor, the full-length cDNA was subcloned
into pcDNA3-Nmyc and pLPC-Nmyc. In both cases, an amino-terminal myc epitope tag
was present in the vector and the fusion site began at amino acid number three of the
predicted protein.
The presence of a T7 promoter in the pcDNA-Nmyc-C144 construct allowed for
the expression of C144 in vitro using a rabbit reticulocyte lysate system to perform in
vitro transcription and translation (IVTT) of C144 (Promega TNT coupled reticulocyte
system). This construct was also transiently transfected into 293T cells to express myctagged C144 in mammalian cells. Western analysis of both the IVTT and ectopically
expressed products using SDS-PAGE revealed that C144 indeed encodes an expressed
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Figure 3-3. T h e conservation of the C C H C zinc fingers of C 1 4 4 .
The CCHC zinc finger of C144 is aligned with a number of other CCHC domain
containing proteins from a variety of organisms. Similar amino acids as determined by
Kyte-Doolittle criteria are shaded in blue and identical amino acids are boxed. Red stars
indicated the conserved canonical CCHC residues that define the CCHC domain.
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protein with an apparent molecular weight of 85 kilodaltons (Figure 3-4). It is interesting
to note that the IVTT C144 product runs as a single band, whereas ectopically expressed
C144 in mammalian cells runs as a doublet. This protein runs as a doublet in both 293T
and HT1080 cells, suggesting that it is not a cell-type specific event. The C144 doublet
suggests that a post-translational modification occurs under physiologic conditions. The
nature of this modification is currently unclear.
Co-immunprecipitation was used to determine if C144 interacts with hRapl and
other known telomere-bound factors. Tagged versions of C144 and other telomere
proteins were transfected into 293T cells and co-IP was performed. These experiments
failed to reveal an interaction between C144 and TRFI, TRF2, or Rapl (Figure 3-5). The
interaction between TRF2 and hRapl serves as a positive control and ability of these
proteins to interact confirmed that the technique worked. Co-immunoprecipitation
experiments using endogenous levels of telomeric proteins rather than this overexpression system were not carried out because attempts to generate antibodies against
C144 were unsuccessful. The two peptides used to generate antibodies were
KYGKGEPKYESKSSKFKSNSDSDYKC and
PHKKQRKETDLTNKEKTKKPTQDSC. Co-immunoprecipitation using endogenous

protein would be more reflective of physiologic conditions and complex formation o
C144 may require more than one binding partner, which would not be detected in an
experiment in which only pairs of proteins are over-expressed.
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Figure 3-4. Protein expression of C144.
A. Calcium phosphate transfection of 293T cells was performed using empty vector and
p c D N A 3 with myc-tagged C144 or TRFI. Whole cells lysates were prepared 48 hr posttransfection and used for immunoblots using an anti-myc antibody.
B. In vitro transcription / translation (IVTT) was performed using the Promega T N T
reticulocyte lysate system with the same plasmids used in A. S35-methionine was added
to the I V T T reaction. The reactions were subjected to S D S - P A G E .
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were performed using either anti-myc or anti-FLAG antibodies. Immunoblots of either
the 1 % of the input or the IP pellet were blotted with either anti-myc or anti-FLAG
antibodies as indicated.
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Figure 3-6. Alignment of C144 and yeast orthologs.
Alignment of C144 in human and its ortholog in S. cerevisiae and S. pombe. Similar
amino acids as determined by Kyte-Doolittle criteria are shaded in blue and identical
amino acids are boxed. The 5. cerevisiae C144 ortholog is Genbank NP_010106;
gi:6320026 and the S. pombe C144 ortholog is Genbank NP_595383; gi: 19112175.
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A n ortholog of C144 was identified in S. cerevisiae in order to test the role of this
gene at yeast telomeres (Figure 3-6). A yeast strain that lacked the 5. cerevisiae C144
was obtained (gift of Harry Scherthan). In order to determine telomere length, genomic
DNA was isolated from wild-type and yeast strains without the C144 ortholog. This
DNA was cut with Xhol and a Southern blot of this genomic DNA was probed with
radiolabeled telomeric probe. The resulting blot indicates that yeast deleted in the
ortholog of C144 did not undergo observable telomere length change over the course of
100 generations (Figure 3-7). In additon, extensive screens for telomere mutants
performed in the Lundblad laboratory failed to implicate this gene (personal
communication).
The second gene identified in the yeast two-hybrid screen is the previously
identified Flice-associated huge protein (FLASH). The yeast two-hybrid fragment in the
prey plasmid contained sequence corresponding to amino acids 1253 through 1455 of the
published FLASH sequence. FLASH (as its name indicates) is a large, 220 kilodalton
protein which was initially pulled out of a two-hybrid screen using procaspase-8/FLICE
as a bait (Imai et al. 1999). FLASH functions as an adapter molecule in the process of
Fas-mediated apoptosis. FasL binds Fas on the cell surface and results in receptor
trimerization, which, in turn, recruits a complex of other factor known as the DISC
(death-induced signaling complex). The formation of the DISC ultimately results in the
processing of procaspase-8 into caspase-8. Caspase-8 is a master caspase that activates
downstream effector caspases and results in apoptosis. The Yonehara group
demonstrated that FLASH co-immunoprecipitates with the DISC, with FADD and with
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S. cerevisiae wild-type and YDL175c delete strains were streaked out for 4 successive
rounds of colony formation (representing approximately 25, 50, 75 and 100 generations).
Genomic D N A was isolated from these yeastand digested with Xhol. Southern blots
were probed with a telomere-specfic radiolabeled probe.
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procaspase-8 (Imai et al. 1999). Full-length F L A S H potentiates Fas-mediated apoptosis
and certain truncated alleles antagonize Fas-mediated apoptosis.
What, then, could be the role of FLASH at telomeres? It is known that
overexpression of dominant-negative TRF2 alleles result in apoptosis and that
deprotected telomeres recruit DNA damage proteins (Karlseder et al. 1999; Takai et al.
2003). One possibility is that FLASH acts as a sensor for telomere dysfunction and
triggers apoptosis when a cell can not properly maintain its telomeres. A full-length
expression construct containing the FLASH open-reading frame was obtained from
Zhengcheng Zheng (Shanghai Institute of Biochemistry). It was difficult to detect overexpressed FLASH in 293T cells and the reason for this is unclear. It could be related to
the relatively large size of FLASH or some aspect of FLASH biology. Anti-peptide
antibodies were generated using the peptides YGKGEPKTESKSSKFKSNSDSDYKGC
and HPHKKQRKETDLTNKEKTKKPTQDSC, but these were unable to recognize a
large molecular weight band consistent with FLASH. IF performed using over-expressed
myc-tagged FLASH demonstrates that FLASH is a nuclear protein and several
(approximately 5 to 10) nuclear foci appear in FLASH-transfected cells. However, these
foci do not colocalize with TRFI, a known telomere protein, in HeLal.2.11 cells (Figure
3-8). The localization of FLASH to telomeres may well be stimulus-dependent or require
the over-expression of Rapl as well. Unfortunately, efforts to raise antibodies against
endogenous FLASH were not successful. Further experiments need to be conducted in
order to determine conclusively whether or not FLASH is at telomeres.
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Figure 3-8. IF of F L A S H and telomere proteins
HeLal.2.11 cells were transfected by electroporation with m y c - F L A S H and cells were
fixed 48 hr post-transfection. IF was performed with anti-myc (green) and anti-TRFl
(red) antibodies along with D A P I stain (blue). Top and bottom are two separate images
using this staining.
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Conclusions

143

This thesis focuses primarily on the identification of human Rifl, an ortholog of
yeast Rifl, and its role as a novel component of the ATM-dependent DNA damage
response pathway. Rifl localizes to sites of inferred DSBs shortly after the induction of
DNA damage and this redistribution requires the function of both 53BP1 and ATM, but
not ATR. RNAi-mediated depletion of Rifl resulted in reduced cell survival after
irradiation. The thesis also focuses on the identification of several putative Raplinteracting factors. Neither C144, a novel zinc finger protein, nor FLASH, the two
candidates obtained from the yeast two-hybrid screen using Rapl as a bait, were
confirmed to be bona fide telomere proteins. Finally, this thesis discusses attempts to
analyze the interaction between the Mrell complex and the TRF2 complex. The
concluding remarks presented here will focus upon human Rifl since it represents the
most promising avenue of future research.

Rifl as an ATM- and 53BP1- dependent DNA damage response factor

The experimental evidence from chapters 1 and 2 strongly support the role of
Rifl in the DNA damage response. Most importantly, human Rifl localizes to inferred
DSBs following ionizing radiation. Rifl is able to form foci in response to several DNA
damage stimuli, including IR, UV, MMS, HU and etoposide. The response to IR takes
place within minutes of exposure. Rifl displays similar kinetics to other known DNA
damage response factors, such as BRCA1, 53BP1 and NBSL Furthermore, Rifl colocalizes with these factors following DNA damage.
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A full description of the exact function(s) of human Rifl in the D N A damage

response was a goal of experiments carried out in this thesis as well as current and future
experimental work. A systematic approach was taken to address which steps of the DNA
damage response cascade require Rifl function. The possible roles of human Rifl at the
outset included Rifl as a primary sensor of DNA damage, Rifl acting at the level of the
PI3K-like transducers ATM and ATR, Rifl as a direct target of ATM, and Rifl as a
player in one of the effector arms of the DNA damage response. The effector pathways
of the DNA damage response include the establishment and maintenance of Gl/S, intra-S
phase, and G2/M cell cycle arrest, the HR and NHEJ repair pathways, damage-dependent
apoptosis pathways, and recovery of cells from damage.
After identifying human Rifl as a bona fide member of the DNA damage
response, it became important to establish where in the DNA damage response pathway
human Rifl lies. The observation that 53BP1 and other DNA damage factors localize to
sites of damage in cells treated with Rifl siRNA indicates that it is unlikely that human
Rifl acts as the sole or dominant sensor of DNA damage. It is possible that Rifl acts as a
redundant sensor in certain situations, but there is no evidence to presently support this
hypothesis. The use of the PI-3 kinase inhibitors caffeine and wortmannin as well as
studies in A-T cells, which lack ATM, indicated that human Rifl is completely
dependent on ATM for its localization to sites of DNA damage. The inability of ATRIP
siRNA to affect human Rifl response to UV or IR supports the hypothesis that Rifl is
dependent on ATM, but not ATR. Further confirmation of this was accomplished by
looking at Seckel cells, which have a splice defect in ATR (H. Takai, unpublished result).
Rifl doe not appear to act at the level of ATM because ATM targets are still
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phosphorylated in Rifl siRNA treated cells. Rifl siRNA treatment also does not
influence the level of ATM auto-phosphorylation in response to DNA damage. Together,
these observations suggest that Rifl acts strictly downstream of ATM.
The dependence of Rifl function on ATM suggests that Rifl might be directly
phosphorylated by ATM. The primary sequence of Rifl contains 14 SQ/TQ sites, the
consensus site of the PI3K-like family members. Rifl contains one site that represents a
more specific consensus sequence (Kim, et al. 1999). Two experimental approaches
were used to address whether ATM phosphorylated Rifl. First, co-immunoprecipitation
experiments in extracts from untreated cells and irradiated cells failed to reveal an
interaction between ATM and Rifl. It was also unclear whether Rifl shifts in
immunoblots in an IR- and ATM- dependent manner. Ongoing experiments using ATM
kinase assays have yielded inconclusive results (S. Buonomo, unpublished observations).
Experiments in which the putative ATM kinase site(s) are mutated have yet to be
executed.
Rifl also requires 53BP1 for its localization to sites of damage following DNA
damage. Rifl requires at least two independent molecular events in order to form DNA
damage foci, since 53BP1 still forms foci, albeit to a lesser extent and with delayed
kinetics, in A-T cells. It has not been formally demonstrated whether ATM-dependent
phosphorylation of 53BP1 is required for Rifl foci formation. The dependence of Rifl
on ATM and 53BP1 is specific. Rifl still forms foci in cells deficient in Mrell, Nbsl,
BRCAl,andChk2.
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The role of Rifl in the D N A damage response effector pathways

The demonstration that cells deficient in Rifl are radiosensitive indicates that
Rifl is necessary for cell survival in response to IR. Further experiments demonstrate
that Rifl siRNA treatment in other cell lines renders these cells radiosensitive, whereas
Rifl siRNA treated cells are not hypersensitive to MMS (H. Takai, unpublished results).
Although these experiments demonstrate the importance of Rifl in the DNA damage
response, the specific mechanism of Rifl in the DNA damage response was sought.
An analysis of the DNA damage response effector pathways was conducted.
Cells are able to halt their progression through the cell cycle in response to DNA damage.
These checkpoints occur at the Gl/S, intra-S phase, and G2/M phases of the cell cycle
and prevent the cell from both replicating damaged DNA and attempting to segregate
damaged chromosomes. The Gl/S transition is examined by assaying BrdU incorporation
following IR, whereas the G2/M transition is observed by looking at the phosphorylation
of hsitone H3 after damage. Experiments conducted by Hiro Takai in the de Lange lab
have demonstrated that Rifl plays a role in the intra-S phase checkpoint. In response to
irradiation, cells halt replication presumably to prevent inappropriate copying of damaged
DNA. Radioresistant DNA synthesis (RDS) occurs if the DNA damage response is not
properly functioning. Two pathways have been described including one pathway in
which Chk2 phosphorylates Cdc25A and results in Cdk2 inactivation and one pathway in
which Nbsl and Mrel 1 play a role (Falck et al. 2001; Falck et al. 2002). Cells treated
with Rifl siRNA display an RDS phenotype. Using cells deficient in Nbsl, a gene
known to be involved in RDS, and complementation with wild type and mutant Nbsl
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alleles, Hiro Takai demonstrated that the Rifl R D S effect is distinct and in a separate
pathway from Nbsl. It is still unclear as to whether Rifl is in the Chk2 RDS pathway.
Thus, Rifl plays a role in S phase progression following IR that is a separate pathway
from the previously described ATM-Chk2-Cdc25A checkpoint pathway.
The ability of Rifl either to participate in or regulate the homologous
recombination (HR) or non-homologous end-joining (NHEJ) pathways that repair the IRinduced DSBs was addressed. A number of repair assays were initiated in an attempt to
determine whether cells deficient in Rifl were competent in terms of DNA repair. These
experiments were technically challenging because it is difficult to separate the damagedependent cell cycle arrest from repair events. Initial experiments did not reveal any
difference in repair events. These experiments involved observations of metaphase
chromosomes after cells were exposed to radiation. Experiments were carried out in
HeLal.2.11 cells treated with caffeine and Rifl siRNA. The interpretation of these

experiments was difficult because it is technically difficult to have cells enter metaphase

after irradiation-induced cell cycle arrest. The effects of cell cycle arrest, caffeine and

repair events must all be considered. The ability of Rifl to act as a direct participant in
either HR or NHEJ is currently unresolved and should be addressed in the future.

Rifl in yeast and human: a unifying view?

The difference between the role of Rifl in yeast and human cells raises questions
about the physiologic function and the evolutionary history of Rifl. Rifl plays a role in
telomere biology in yeast cells, whereas Rifl plays a role in the DNA damage response in
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human cells. There are several speculative possibilities that could explain this apparent
discrepancy.
Rifl could function in both the DNA damage response in both yeast and human
cells. There is evidence to suggest that Rifl plays a role in DNA damage in yeast. Rifl
deficiency results in a 10 fold increase in chromosome loss rates per generation; Rif2
deficiency results in a 4 fold increase in chromosome loss rate and loss of both Rifl and
Rif2 leads to a 40 fold increase in chromosome loss (Wotton and Shore 1997). It is not
known whether this chromosome instability is associated with a DNA damage response
role for Rifl in yeast. However, rifl-A yeast do not have a GCR phenotype (Myung et al.
2001). As mentioned previously, Rifl is in the Tell and Mecl pathways in terms of
telomere length. There is currently no evidence that Rifl is involved in telomere biology
in human cells. However, it is tempting to speculate that the telomere and DNA damage
functions of Rifl are related. S. cerevisiae could have co-opted the DNA damage factor
Rifl to protect its telomeres and Rifl may actually not function in telomere biology in
mammalian cells.

Human Rifl and telomere biology

Although the experiments described in chapter 1 have failed to detect Rifl at
functional human telomeres, further studies need to be carried out in order to establish a
possible role for Rifl in human telomere biology. It is critical to determine whether nor
not human Rifl plays a role at functional telomeres. One avenue of research involves the
use of an RNAi hairpin (shRNA) expressed from retroviruses in order to assess the role
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of Rifl in telomere length regulation. Since the R N A i strategy described in chapter 2 can
not be used in long term experiments, shRNA might prove ideal for the study of telomere
length, which requires successive passaging of cells. Additionally, the examination of
the effects of over-expressed alleles of Rifl may elucidate possible roles of this protein
telomeres.
So far, we have not been able to detect Rifl at human telomeres. However, the
fact that Rifl has a telomeric function in S. pombe argues in favor of a role for Rifl at
human telomeres. The structure of fission yeast telomeres more closely resembles that of
human telomeres than the budding yeast telomeric complex. As discussed above, further
experiments will be required to determine whether Rifl also plays a role at human
telomeres. Although there have been several possibilities presented, it is still unclear
why exactly Rifl has apparently disparate roles in telomere biology in yeast and in the
DNA damage response in human cells.

Rifl in human disease and clinical therapy

Human Rifl, encoded by a gene on chromosome 2 (2q23.3), is a candidate tumor
suppressor. This view is based on its involvement in the ATM pathway which contains
other tumor suppressors, including ATM itself, Mrell, Nbsl, BRCA1, and Chk2. Similar
to mutations in these genes, changes in human Rifl may play a role in certain sporadic or
familial human cancers. Treatment of cells with Rifl siRNA did not reveal an acute cell
lethal phenotype upon Rifl inhibition. Mutations in Rifl may therefore be tolerated in the
germline. Such heterozygous individuals could be at risk for development of cancer if
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loss of heterozygosity ( L O H ) at the Rifl locus leads to cells with impaired ability to
respond to DNA damage.
Recent data regarding the mouse ortholog of Rifl suggests that Rifl may have an
entirely different role in development because mouse Rifl was highly expressed in germ
cells and embryo-derived pluripotent stem cells (Adams and McLaren 2004). It is
possible that Rifl still functions in the S-phase RDS pathway and that this pathway plays
an important physiologic function in early cell division and development. Thus, it is
possible that loss of function mutations may not be tolerated in human cells. The
generation of mouse that lacks Rifl is on-going (S. Buonomo, personal communication)
and could address the issue of whether lack of Rifl contributes to heritable, spontaneous,
or induced tumorigenesis in vivo.
The strict dependence of Rifl on ATM is unusual among the substrates of this
kinase, which generally also respond to regulatory inputs from ATR. Because of this
unique regulation, IR-induced Rifl foci are an excellent indicator for ATM kinase
activity. A cell-based assay for ATM activity based on Rifl foci could rapidly identify
individuals with alterations in this pathway and could reveal the ATM status of tumor
samples, potentially improving cancer diagnosis and treatment. Furthermore, the Rifl
assay could be helpful in the identification of ATM inhibitors, which have potential
application as radiosensitizing agents. Additionally, drugs targeting Rifl directly may
serve as radiosensitizing agents with applications in the clinic.
A final application of Rifl in the clinic could be the use of genetic testing. If
Rifl turns out to be involved in human tumorigenesis (particularly intriguing given the
role of several other DNA damage response factors in human cancer predisposition

151

syndromes), mutations of Rifl could be characterized and screening paradigms can be
designed to aid in patient care. Importantly, Rifl status may serve as a prognostic marker
for the responsiveness of individual tumors to radiotherapy. Since cells deficient in Rifl
are radiosensitive, one might reasonably predict that tumors lacking Rifl and other DNA
damage response factors would undergo a more dramatic response to radiation therapy.
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A p p e n d i x - Investigating h o w the
c o m p l e x interacts w i t h t h e T R F 2
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M r e l l
complex

Introduction
The previous chapter discussed the use of a genetic method, the yeast two-hybrid
screen, to search for novel Rapl-interacting factors. Work in the de Lange lab has led to
the discovery of several Rapl-interacting factors in mammalian cells. In addition to
TRF2, which interacts tightly with Rapl and brings it to human telomeres, the Mrell
complex, including Mrell, Rad50 and Nbsl, has been shown to be present in a complex
with TRF2 and hRapl (Zhu et al. 2000). Most of the Mrell complex is nucleoplasmic
and only a small percentage of Mrell complex components is localized to the telomere
(Zhu et al. 2000). This is demonstrated by the observation that Triton X-100 preextraction of a large quantity of nucleoplasmic Mrell complex is required in order to
visualize the co-localization between the Mrell complex and the telomeric protein TRFI
by IF (Zhu et al. 2000). Although the Mrell complex is a component of IRIFs, the
telomeric proteins TRFI and TRF2 do not re-localize to IRIFs (Zhu et al. 2000).
Furthermore, Nbsl is phosphorylated in S phase and its localization at telomeres only
occurs during S phase (Zhu et al. 2000). It is unclear what the role of the Mrel 1 complex
is at human telomeres. As discussed in the introduction, the Mrell complex contains
several enzymatic activities that may have a role in t-loop processesing and the Mrell
complex is known to play a role in telomere length regulation in S. cerevisiae.
In order to further extend these observations, the specific binding interactions
between the TRF2-hRapl-Mrell complex must be defined and characterized. Although
it is known that the Mrell complex is found in a complex with TRF2, it is unclear
whether this interaction is dependent upon hRapl. It is also unclear which component of
the Mrell complex binds to TRF2, hRapl, or a third protein that interacts with either
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T R F 2 or Rapl.

T w o approaches were taken to further study the protein-protein

interactions between TRF2, Rapl and the Mrell complex. The first approach involves
using a GST-hRapl fusion to attempt to pull down baculovirus-derived Mrell complex.
The second approach involves using baculovirus-derived Mre 11 complex to attempt to
supershift TRF2-DNA or Rap 1-TRF2-DNA complexes in electromobility shift assays
(EMSAs).
Results and discussion
In order to study the interactions between the TRF2 complex and the Mrell
complex, the components of these complexes were produced in vitro through various
methods. A baculovirus system was used to product TRF2, hRapl, and the Mrell
complex (Figure 4-1A). The TRF2 and hRAPl baculoviruses were previously
constructed in the de Lange lab (Broccoli et al. 1997a; Li et al. 2000), while the Mrell
complex baculoviruses were a generous gift of Tanya Paull and Martin Gellert (Paull and
Gellert 1998; Paull and Gellert 1999). The baculoviruses for Mrell, Nbsl, and Rad50
must be used together to infect insect cells in order to obtain a stable Mrel 1 complex in
vitro. Mrell can be produced alone, but Nbsl and Rad50 each require Mrell for their
stability. It is unclear whether the mechanism underlying the requirement of Mrell for

the stability of Nbsl and Rad50 is co-translational or post-translational. The purity of th
baculovirus-derived proteins was assessed through Coomassie-staining (Figure 4-1 A).
Mrell protein itself could be isolated at high yield and purity (Figure 4-1 A). The
Mrell/Nbs 1/Rad50 complex yielded less protein and relatively more contaminants
(Figure 4-1 A). Additionally, antibodies that recognize Mrell, Nbsl, and Rad50 reacted
with bands of the appropriate size (Figure 4-IB).
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Figure 4-1. Baculovirus-derived Mrell and Mrell complex.
A. Mrel 1 alone or Mrel 1, Nbsl and Rad50 baculoviruses (gifts of Tanya Paull and
Martin Gellert) were used to infect SF21 insect cells. Each Mrel 1 complex component
was His-eptiope tagged. Cell lysates were prepared 40 hr post-infection. Lysates were
purified using nickel beads. Samples were run out using S D S - P A G E and stained with
Coomassie Brillant Blue G.
B. Baculovirus-derived Mrel 1 complex is immunoblotted with antibodies recognizing
Mrel 1, Rad50 and Nbsl as indicated.
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Blot: Nbsl

The complex presented here looks the same as the purified Mrel 1/Nbsl/Rad50 complex
(Carney etal. 1998).
In order to perform G S T pulldown experiments, hRapl was cloned into the
p G E X - 2 T K plasmid by P C R to give a GST-hRapl expression construct. E. coli (B21
strain) were transformed with this plasmid to produce GST-Rap 1 protein (Figure 4-2A).
Protein concentration was determined through the Bradford assay and comparing the
GST-hRapl fusion to known quantities of B S A on Coomassie-stained gels following
S D S - P A G E (Figure 4-2A). Protein purity was determined by examining these gels and
observing a prominent band at the correctly predicted molecular weight of 73 k D (Figure
4-2A).

There are a number of other bands in this preparation (Figure 4-2A).

An

immunoblot of the GST-hRapl fusion with an antibody that recognizes hRapl reveals
both that the 73 k D band indeed contains hRapl and that the bands seen in Figure 4-2A
also contain hRapl (Figure 4-2B). Degradation is the most likely explanation for these
smaller molecular weight bands (Figure 4-2B).
The first approach used involved attempts to pulldown baculovirus-derived
M r e 11 complex with a GST-Rap 1 fusion protein. Early experiments gave an impression
that GST-Rapl could indeed pulldown the Mrell complex (Figure 4-3). W h e n the
experiment was reproduced, there was some degree of binding of the Mrel 1 complex to
G S T alone. A number of different conditions were attempted, including the addition of
baculovirus-derived T R F 2 and the use of S D S / TritonX-100. T R F 2 was added to
possibly stabilize the complex and S D S / Triton X-100 was used to decrease the
background binding of the Mrel 1 complex. Further attempts reveal that, while
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Figure 4-2 Preparation of G S T and GST-Rapl proteins.
A. G S T and GST-hRapl was produced in BL21 strain E. coli. Cell lysates were made
and proteins were purified using glutathione sepharose beads. Samples were run out
using S D S - P A G E and stained with Coomassie Brilliant Blue G. The top and bottom gels
shown are 7 % and 9 % SDS-PAGE, respectively.
B. Immunoblots of the G S T and GST-hRapl samples in A were probed with an antibody
recognizing hRapl.
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GST

Figure 4-3. GST-hRapl pulldown of the Mrell complex, T R F I and T R F 2 .
G S T and GST-hRapl were used to pulldown baculovirus-derived Mrel 1 complex, TRFI
and TRF2. Mrel 1 complex was added in the top three blots, TRFI in the lower left blot
and T R F 2 in the lowerrightblot. Immunoblots were performed on the samples using
antibodies recognizing Mrel 1, Rad50, Nbsl, TRFI and T R F 2 as indicated. 1 % input
was loaded in lanes designated as input.
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promising, the background binding of the Mrel 1 complex continued to be a problem.
There is a strong enrichment of baculovirus-derived TRF2 in a pulldown with GSThRapl relative to a pulldown with GST alone (Figure 4-3). Although there is a bit of
background binding with baculovirus-derived TRFI, there is a small enrichment in GSThRapl in comparison to GST alone pulldown (Figure 4-3). These controls demonstrate
that GST-hRapl behaves as expected in terms of its ability to bind to Rapl and its
inability to interact with TRFI. However, the amount of enrichment of TRFI is not
completely insignificant.
Another approach to understanding the binding interactions between the TRF2hRapl complex and the Mrel 1 complex is the use of electrophoretic mobility shift assay
(EMSA), also known as gel-shift analysis. A labeled probe containing twelve TTAGGG
double-stranded repeats corresponding to human telomeric DNA was used to assay the
ability of the Mre 11 complex to supershift or affect the mobility of TRF2-telomeric DNA
or Rapl-TRF2-telomeric DNA complexes. This system was originally developed to
assay the ability of TRFI to bind telomeric DNA (Bianchi et al. 1997). is capable of
binding telomeric DNA directly and producing an EMSA shift. Human Rapl, while
unable to bind DNA directly, can supershift a TRF2-DNA complex (Broccoli et al.
1997a; Li et al. 2000). Initial attempts were performed to determine if baculovirusderived Mrell or Mrell complex could supershift TRF2-DNA (Figure 4-4). The initial
data was promising in that Mrell complex appeared to shift the TRF2-DNA complex
(Figure 4-A lanes 5 and 9). Although some of this data appeared promising, a technical
problem involved the fact that the Mrel 1 complex was fairly dilute and a large amount of
salt was added to the EMSA reactions along with Mrel 1 complex protein. The salt
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Figure 4-4. Gel shift analysis to determine if Mrell complex can supershift a T R F 2 D N A complex.
A. E M S A performed using the indicated quantities of baculovirus-derived T R F 2 and/or
Mrell complex prepared with 450 m M KCI and a radiolabeled probe containing twelve
T T A G G G telomeric duplex repeats.
B. Same as in A., except that Mrel 1 complex dialyzed against 150 m M KCI is used.
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carried along with the Mrell complex may affect the T R F 2 - D N A complex and give the
appearance that Mrell complex is able to supershift the TRF2-DNA complex. In order
to solve this problem, Mrell complex was prepared as previously, but was dialyzed
against 150 mM KCI to lower the amount of salt. The EMSA experiments were then
repeated (Figure 4-4B). Although these experiments were repeated numerous times
under varying protein concentrations, no evidence exists that conclusively and
reproducibly indicates that Mrel 1 complex is able to supershift the TRF2-DNA complex.
Mrel 1 complex may also be recruited to the telomere through Rapl. As a result,
EMSA was performed to determine whether or not the Mrel 1 complex could supershift
the Rapl-TRF2-DNA complex. Rapl is able to supershift the TRF2-DNA complex ((Li
et al. 2000), Figure 4-5). Baculovirus-derived Mrell or Mrell complex were added to
the Rapl-TRF2-DNA complex (Figure 4-5A and 4-5B, respectively). Although there

may be small effects on the shift, these are not reproducible. It is unclear whether this i
due to the gel shift conditions used, the quality of the protein preparations, or reflects
biology of the Mrel 1 complex.
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Figure 4-5. Gel shift analysis to determine if Mrell complex can supershift a RaplT R F 2 - D N A complex.
A. E M S A performed using the indicated quantities of baculovirus-derived T R F 2 , Rapl,
and/or Mrel 1 and a radiolabeled probe containing 11 T T A G G G telomeric duplex repeats.
B. Same procedure as in A., except that Mrel 1 complex dialyzed against 150 m M KCI is
used.
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Methods

Yeast Two-Hybrid library-scale transformation

The library transformation of L40 yeast cells was performed as follows. A fulllength human Rapl fused to LexA or a carboxy-terminal human Rapl fused to LexA
were used to screen transformants from of a human fetal liver two-hybrid library
(Clontech) created in p G A D l O . A n overnight culture of the yeast bait strain was grown
at 30 °C in appropriate dropout media. A 50 ml culture was then inoculated with 0.25 ml
of the overnight culture and grown overnight at 30 °C. 200 ml of Y P D (prewarmed to 30
°C) was inoculated with enough culture to give O D 6 0 0 of 0.3 and cells were grown for 3
hours at 30 °C (at least one doubling). Cells were pelleted at 2.5 K for 5 min at room
temperature, resuspended in 100 ml T E (10 m M Tris-HCl p H 8.0 / I m M E D T A ) , pelleted
agan and resuspended in 4 ml 100 m M LiOAc / 0.5 X T E (10 m M Tris-HCl p H 8.0 /
I m M E D T A ) . 0.2 u L denatured carrier D N A (10 m g / ml) and 50 micrograms of library
D N A was then added. Then, 28 ml 100 m M LiOAc / 4 0 % polyethylene glycol / lx T E
(10 m M Tris-HCl p H 8.0 / I m M E D T A ) was added, mixed, and incubated 30 min at 30
°C with gentle shaking. 3.5 ml dimethyl sulfoxide was added with swirling to mix and
cells were heat shocked at 42 °C for 6 min with occasional swirling. After heat shock,
cells were immediately diluted with 80 ml Y P D and cooled to room temperature in a
water bath. The cells were pelleted at 2.5 K for 5 min at room temperature, washed with
100 ml Y P D resuspended in 200 ml Y P D (prewarmed to 30 °C) and incubated at 30 °C
for 1 hr with gentle shaking. Cells were pelleted again at 2.5 K for 5 min at room
temperature and resuspended in 100 ml S D -Trp, - Leu. 10 u L and 1 iiL of this were
plated on S D -Trp, -Leu to allow a determination of the number of transformants plated
during the screen. The remaining cells were pelleted and resuspended in 200 ml S D
-Trp, -Leu (prewarmed to 30 °C) and incubated at 30 °C with shaking between 4 hr and
16 hr. Cells are pelleted, washed twice with S D -Trp, -Leu, -His and resuspended in 10
ml S D -Trp, -Leu, -His. Plate 0.1 u L and 0.01 uL on S D -Trp, -Leu to assess number of
tranformants plated and plate 10 ml on 50 S D -Trp, Leu, -His plates and incubate at 30
°C.
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Yeast transformation

Yeast transformation was performed as follows. The yeast strain to be
transformed is grown to mid-log phase (OD600 = 0.6 - 0.8). Cells are harvested in a
clinical centrifuge for 15 min at 10 K at 4 °C and resuspended in 1/2 total volume of 1 x
Y T B . Cells are centrifuged for 15 min at 10 K at 4 °C again and resuspended in 1ml of
IX Y T B per 50 ml starting culture. For each transformation, 50 uL of cells are placed in
an eppendorf tube. Add 5 u L of boiled carrier D N A at 5 mg/ml (eg herring sperm D N A )
and the plasmid or library D N A (usually 1 to 5 u,L). Shake gently to mix, add 0.5 ml of
polyethylene glycol 4 0 % / LiAc / T E (10 m M Tris-HCl p H 8.0 / I m M E D T A ) solution,
vortex and incubate at 30 °C for 30 min without shaking. Heat shock the cells at 42 °C
for 20 min, spin tubes in microfuge for 2 min at setting 3, wash cells once with 0.5 ml of
H20, resuspend cells in 0.3 ml of H 2 0 and plate on appropriate nutritional selection
plates.
A "quick" method of yeast transformation was also used. In this method, a 2 x 2
c m patch of the yeast strain to be transformed was grown at 30 °C. The patch is collected
with a sterile toothpick and placed in an eppendorf tube with H20. The cells are spun
down, the H 2 0 is aspirated, and cells are resuspended in 0.7 ml 4 0 % polyethylene glycol
/ 0.1 M LiOAc / T E (10 m M Tris-HCl p H 7.5 / I m M E D T A ) . 5 liL of herring sperm
D N A (5 mg/ml) and 3 liL of D N A are added and the tube is incubated at room
temperature overnight. The following day, the tubes are heat shocked at 42 °C for 20
min, spun 2 min at speed 3, and the pellets are washed once with 0.5 ml H20. The cells
are then resuspended in 300 u L H 2 0 and plated on appropriate nutritional selection
plates.

Yeast protein extracts

Yeast protein extracts were prepared from 50 ml of yeast culture grown to midlog phase (OD600 approximately 0.5) at 30 °C. The culture is then centrifuged at 2.5 K
for 5 min at 4 °C and washed once with sterile, ice-cold H20. The pellet is resuspended
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in 0.5 ml 2 X Laemelli buffer (125 m M Tris-HCl, 4 % SDS, 2 0 % glycerol, 1 0 %
mercaptoefhanol, 0.004% bromophenol blue). The samples are then transfered to an
Eppendorf tube containing 100 ul glass beads, vortexed 1 min, boiled 5 min, and placed
on ice for 3 min. The vortex and ice steps are repeated three times and samples are
centrifuged at 14 K for 1 min at 4 °C. Finally, transfer supernatant to new tube and store
at-80°C.

Yeast plasmid isolation

In order to isolate plasmid DNA from yeast, a 3 cm x 3 cm patch of the
appropriate yeast strain was grown and collected with a toothpick into 0.5 ml H 2 0 in an
Eppendorf tube. The cells are spun down at 3 K for 2 min at room temperature and the
supernatant is aspirated. The cells are then resuspended in 100 u L S T E T (50 m M TrisHCl p H 8.0, 50 m M E D T A , 8 % sucrose, 5 % Triton X-100) and then 0.2 g of glass beads
area added. The tubes are vortexed at room temperature for 15 min, another 100 u L
S T E T (50 m M Tris-HCl p H 8.0, 50 m M E D T A , 8 % sucrose, 5 % Triton X-100) are added
and the tubes are vortexed for 10 min after which they are centrifuged at 14 K for 10 min
at 4 °C. 100 u L of the supernatant is removed, combined with 100 u L 4 M ammonium
acetate, and then stored at -20C for at least 1 hr. Tubes are spun at 14 K for 10 min at 4
°C and 150 u L of supernatant is transferred to new tube with 200 u L ice-cold E t O H and
incubated for at least 15 min at -20 C. Tubes are spun again 14 K for 15 minutes at 4 °C.
Aspirate the supernatant, speedvac to dry the D N A pellet and reuspend in 20 u.L 0.1 x T E
(10 m M Tris-HCl p H 8.0 / I m M E D T A ) .

P-galactosidase filter lift assay

To perform the |3-galactosidase filter lift assay, yeast strains are first grown on
plates. Afilter( V W R qualitative diameter 7.5 c m grade 410, cat. # 28321-055) is placed
on top of the cells, removed and placed in liquid N2 for 20-30 sec, allowed to warm to
room temperature and then placed in liquid N2 for another 20-30 sec and allowed to warm
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to room temperature again. Anotherfilteris placed in an empty Petri dish and covered
with 1 ml of Z X solution (10 ml Z buffer, 27 ul beta-mercaptoethanol, and 500 ul X-gal
stock (20 mg/ml in D M F ) forfinalconcentration of 1 mg/ml; Z buffer is 16.1 g/L
Na2HPO4-7H20, 5.5 g/L NaH2P04-7H20,0.75 g/L KCI and 0.246 g/L MgS04-7H20.
The originalfilteris placed, cell side up, on top of the wettedfilterin the Petri dish and
another 100-300 ul of Z X buffer is added. Eliminate bubbles and place in 37 °C
incubator. Thefiltersare observed and the time required for a given colony to turn blue
is recorded.

Quantitative P-galactosidase assay

To perform the quantitative beta-galactosidase liquid culture assay, the
appropriate yeast strains are grown to an ODgoo between 0.5 and 0.8. The exact O D is
recorded. Then, place 1.5 ml of culture in an Eppendorf tube, centrifuge 14 K for 30 sec
at room temperature and aspirate the supernatant. Wash and resuspend pellet in 1.5 ml Z
buffer, spin down cells, and resuspend in 300 lambda Z buffer. After pipetting 100
lambda into a new Eppendorf tube, place tubes in liquid N 2 and then thaw cells at 37 C in
water bath for 1 min. After also setting up blank tube with 100 lambda Z buffer, add 0.7
ml of Z buffer (16.1 g/L Na2HPO4-7H20,5.5 g/L NaH2P04-7H20,0.75 g/L KCI and 0.246
g/L MgS04-7H20) and P-mercaptoethanol to the reaction and blank tubes. Start a timer
as one adds 0.16 ml O N P G to reaction and blank tubes and places in 30 C incubator. T o
stop the reactions add 0.4 ml 1 M Na2C03 to reaction and blank and record time. After
spinning tubes at 14K at room temperature, the OD420. Calculate the standard units by the
following formula: beta-galactosidase units = (1000 x OD420) / (t x V x O D 6 0 0 ) where t
= elapsed time in minutes of incubation and V = 0.1 ml x concentration factor.

Yeast telomere blot

The isolation of genomic DNA from yeast is the first step in the yeast telomere
blot. T o perform this, 8-10 ml culures of appropriate yeast strains are grown on a roller.
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The cultures are then centrifuged at 14 K for 10 minutes at 4 °C, the supernatants are
aspirated and the pellets are resuspended in 1 ml H 2 0 and transferred to Eppendorf tubes.
The samples are centrifuged 14 K for 5-10 sec and the supernatant is aspirated. The
pellets are then resuspended in 0.6 ml of a sorbitol/EDTA/zymolase solution (For 10 ml
of 0.9 M sorbitol / 0.1 M E D T A solution, add 3 m g of powdered zymolase 20,000 and 20
ul of beta-mercaptoethanol; 1 L of sorbitol / E D T A solution made by adding 550 ml H 2 0
to flask, then 163.98 g sorbitol, 200 ml 0.5 M E D T A , mix and bring up to 1 L) made
fresh and incubated at 37 °C for 1 hr. The samples are centifrigued 14 K for 5 sec, the
supernatants are aspirated and the pellets are resuspended in 0.6 ml T E (10 m M Tris-HCl
p H 8.0 / I m M E D T A ) . 120 ul EDTA/Tris/SDS solution (2 ml 0.5 M E D T A , 1 ml 2 M
Tris base, 0.5 ml H20, and 0.5 ml 2 0 % SDS) is added to each sample. The samples are
mixed gently by inverting the tubes and then they are incubated at 65 °C for 30 min.
Following this, 200 ul 5 M K O A c is added to each sample and the samples are mixed
completely by inverting and incubated on ice for 1 hr. The samples are then spun down
in a centrifuge 14 K for 15 min at 4 °C, the supernatants are poured off carefully into into
fresh tubes containing 550 ul of isopropanol and the tubes are mixed immediately by
inverting the tubes. The samples are centrifuged 14 K for 10 minutes at 4 °C, the
supernatants are decanted and the pellets are washed with 1 ml 7 0 % ethanol, centrifuged
at 14 K for 2-5 minutes at 4 °C and the supernatants are carefully aspirated. The pellets
are then dried for 5-10 min on a SpeedVac. After drying, the pellets are resuspended in
500 ul T E + 3 ul RNase and incubated at 37 °C for 1 hr (vortexing the tubes briefly at 30
min). The samples are then centrifuged 14 K for 15 min at 4 °C and the supernatant is
transferred to a new tube. 20 ul of 5 M NaCl and 300 ul isopropanol is added to each
sample and then the tubes are inverted to precipitate the D N A . The samples are
centrifuged 14 K for 10 min at 4 °C, the supernatants are decanted, the pellets are washed
with 7 0 % ethanol. After the samples are again centrifuged 14 K for 10 min at 4 °C, the
ethanol is aspirated and the pellets are dried in a speed-vac. Finally, the samples are
resuspend in 20 nl T E (10 m M Tris-HCl p H 8.0 / I m M E D T A ) and vortexed well to
resuspend the pellets.
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The radiolabeled telomere probe is made according to the following protocol. T o
prepare poly(dA-dC)-poly(dG-dT) D N A (Pharmacia Biotech), resuspend at 1 U/ml T E
(50 ng/ul) and then further dilute to a concentration of 10 ng/ul. The telomere probe is
made via random priming using the Megaprime D N A labeling system kit (Amersham).
First, 5 ul poly(dA-dC)-poly(dG-dT) D N A is aliquoted into an Eppendorf tube and then
15 ul H 2 0 is added to afinalvolume of 20 ul. The D N A is then dantured 95°C for 10
min, snap cooled on ice for 5 min. and briefly spun to collect contents. The following are
then added in order: 5 ul primer solution, 5 >ul reaction buffer, 4 ul cold dATP, 4 ul cold
d T T P (from Amersham kit thus far), 5 ul radioactive dGTP, 5 ul radioactive dCTP, and 2
ul Klenow. The reaction mix is then incubated at 37°C for 30 min and the D N A is then
precipitated by adding 50 ul T E (10 m M Tris-HCl p H 8.0 / I m M E D T A ) , 1 ul glycogen,
50 ul 7.5 M ammonium acetate, and 300 ul 9 5 % ethanol. The mixture is then left to
stand at room temperature for 15 min. The supernatant is removed carefully with a
pasteur pipet and dispensed into a clean eppendorf (save this). The pellet should be
visible as a small white pellet (due to the glycogen). The pellet is washed with 300 ul
7 0 % ethanol and mixed by inverting. The samples are then centrifuged 14 K for 2 min at
4°C and the supernatant if removed. The amount of radioactivity incorporated into the
probe is then estimated by comparing the amount of signal from the tube of radioactive
supernatant with the tube of the actual probe. The probe should have at least 3 0 % of the
radioactivity incorporated into the probe. The probe is then dried using a Speedvac for 510 min, and resuspend in 200 fil T E (10 m M Tris-HCl p H 8.0 / I m M E D T A ) .
The telomere blot for S. cerevisiae samples is performed as follows. First,
yeast genomic D N A samples are digested with Xhol. Approximatedly 5 to 8 pil of a
standard yeast D N A prep (i.e. 8 to 10 ml of yeast prepped into 20 ]A of D N A ) is used and
1 to 2 fi\ of Xhol enzyme and appropriate buffer is added in a 20 p\ total reaction volume.
The D N A is digested at 37°C for a minimum of 4 hr. The samples and molecular weight
markers are subjected to electrophoresis on a large agarose gel at 55 volts (for about 1618 hr). Prior to transfer, a picture of the gel is taken with a ruler aligned with the
molecular weight markers and the top marking the top of the well. The gel is then soaked
in denaturation solution for 30 min (the solution is changed after 15 min). A Hybond N
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membrane is cut and the gel is blotted overnight in 10 X SSC. The D N A is then
crosslinked to the membrane using U V , the membrane is pre-hybridized in telomere
hybridization solution (6 X SSC, 4 X Denhardt's reagent, 0.5 % SDS, 25 micrograms /
ml E. coli D N A ) at 60°C for 6 hr, and the blot is hybridized in telomere hyrbidization
solution with telomeric probe prepared as above (and denatured 95°C for 5 min and
quickly cooled on ice just prior to use) at 60°C for at least 16 hr. The blot is then washed
four times in 4 X SSC, 0.1% S D S for 15 min each and three times in 0.1 X SSC, 0.1%
S D S for 10 min each while monitoring with a Geiger counter. The blot was then exposed
overnight on a phosphorimager.

Cell culture

Cells were passaged by treatment with trypsin and seeding at appropriate
densities per cell line. Cell numbers were determined by using a Coulter Counter to
assay a 1:20 dilution of cell suspension in diluent fluid. For cell freezing, cells were
harvested, washed with media and resuspended in approximately 0.5 ml 2 x A freezing
solution (40 ml F B S (Hyclone), 0.4 ml gentamycin stock solution [stock is 50 mg/ml
gentamycin from Sigma], 4 ml H E P E S stock solution [stock is 1 M H E P E S p H 7.6], and
156 ml L15 media (Sigma) and is sterilized through a 0.2 micronfilter]per 10 cm2 plate.
0.5 ml of 2 x D freezing media (40 ml P V P stock solution [stock is 100 m g P V P (Sigma)
per ml of HEPES-buffered saline, 30 ml D M S O (Sigma), 4 ml H E P E S stock solution
[stock is 1 M H E P E S p H 7.6], and 126 ml L15 media (Sigma) and is sterilized through a
0.2 micronfilter)is then added and 1 ml of each mixture is added per cryovial. The vials
were placed in a room temperature Styrofoam box at -80°C overnight before being
transferred to a liquid N2 storage container several days later.
I M R 9 0 primary human fibroblasts (ATCC), AG02496 and AG04405 primary AT fibroblasts (Coriell Cell Repository), SV40-transformed NBS-1 LB1 cells ((Zdzienicka
1999); a gift from Margaret Zdziencka), and A T L D - 3 and A T L D - 4 cells (Stewart et al.
1999), a gift from John Petrini) were grown in D M E M , 1 5 % fetal bovine serum. HeLa
and 293T cells were grown in D M E M , 1 0 % bovine calf serum. U 2 0 S cells ( A T C C ) were
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grown in McCoy's modified medium with 1 0 % fetal bovine serum. H C C 1 9 3 7 cells
( A T C C ) and HCT-15 cells ( A T C C ) were grown in R P M I media with 1 0 % fetal bovine
serum and 1 m M sodium pyruvate. All media were supplemented with 2 m M Lglutamine, 0.1 m M non-essential amino acids, 100 units of penicillin per ml and 0.1 m g
of streptomycin per ml.
For IR treatment, cells were exposed to y-irradiation using a Cs137 source at a rate
of 770 rad/min in 6 cm2 dishes. For U V radiation, cells were washed with P B S and
exposed to 25 J/m2 U V radiation (265 n m ) in a Stratalinker (Stratagene). The lid was
removed from the dishes just prior to U V radiation and replaced immediately after this
treatment. After U V radiation, cells were incubated in media until harvest. M M S and
etoposide (0.01% w/v and 50 mg/ml, respectively) were added to the media and cells
were incubated for 1 hr before harvesting. Caffeine and wortmannin (20 m M and 100
m M , respectively) were added to the media 2 hrs and 1 hr, respectively, before
irradiation.

Antibodies

Antibodies 1025 and 1060 were affinity purified from rabbit serum immunized
with keyhole limpet haemocyanin-conjugated Rifl peptides ( N S E S D S S E A K E E G
S R K K R S G K W K N K and E E G I I D A N K T E T N T E Y S K S E E K L D N ; both with an added Cterminal Cys residue). Peptides were obtained from Bio-synthesis Incorporated and rabbit
serum obtained from Covance Research Products. K L H was obtained from Pierce.
Serum obtained from mice immunized with the KLH-conjugated 1060 peptide was also
used but without affinity purification. Antibodies 1066 and 1067 are crude serum from
rabbits immunized with a G S T fusion protein consisting of G S T fused to a portion of
Rifl extending from amino acid 907 to amino acid 1327.
For other proteins, following antibodies were used: TRFI, 371 ((van Steensel and
de Lange 1997)); TRF2, 647 ((Smogorzewska et al. 2000)); A T M 2C1 (GeneTex);
phospho-ATM Ser 1981 ((Bakkenist and Kastan 2003); a gift from Mike Kastan);
ATRIP-N ((Cortez et al. 2001); a gift from Steve Elledge); B R C A 1 Ab-1 (Oncogene
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Research Products); phospho-BRCAl Serl524 (Oncogene Research Products); phosphoChkl Ser317 (Cell Signaling); phospho-Chkl Ser345 (Cell Signalling); F A N C D 2 (a gift
from Arlene Auerbach); g-H2AX Ser 139 (Upstate); phospho-Histone H 3 Ser 10
(Upstate); Nbsl ((Maser et al. 2001); a gift from John Petrini); phospho-p53 Serl5 (Cell
Signalling); p53, D O l (Santa Cruz); phospho-Radl7 Ser 645 (Cell Signalling); 53BP1
((Schultz et al. 2000); a gift from Thanos Halazonetis); a-tubulin clone B-5-1-2 (Sigma);
and g-tubulin clone GTU-88 (Sigma).
T o prepare whole cell lysates, cell were trypsinized, washed once with media,
washed once with cold P B S , counted and resuspended at 1 x IO4 cells/ml 4 X Laemmli
buffer (0.24 m M Tris-HCl, 4 % S D S , 2 0 % glycerol, 1 0 % beta-mercaptoethanol, 0.004%
bromophenol blue), boiled for 10 min and then sheared through a 28 gauge insulin
syringe. T o prepare buffer C extract, cells were trypsinized, washed once with media,
twice with ice-cold P B S , and incubated in buffer C (van Steensel et al. 1998) on ice for
30 min. After centrifugation at 4°C for 10 min at 14 K, the supernatant was collected and
the Bradford assay was used to determine protein concentration. The extract was then
combined with Laemmli buffer and boiled for 10 min. Protein samples were separated by
S D S - P A G E and blotted to either nitrocellulose or P V D F (for A T M ) membranes.
Membranes were blocked in 1 0 % non-fat powdered milk/0.5% Tween-20 in P B S for 30
min at room temperature and incubated with primary antibodies in 0.1% non-fat
powdered milk/0.1% Tween-20 in P B S (IB) at 4°C overnight. Membranes were washed
three times in IB, incubated with secondary antibody in IB for 40 min at room
temperature, washed three times with IB, twice with P B S , and once with H20. E C L
(Amersham) was applied and membranes were exposed to film.

GST pulldowns

This protocol was obtained from the Amersham Pharmacia biotech manual and
Edward Yang. Large scale bacterial sonicates were obtained by growing BL21 bacteria
in 2 x Y T A at 20-30°C with shaking until mid-log phase. 100 m M stock of IPTG was
added to give afinalconcentration of 1 m M and cells were grown from 2-6 hr at 30°C.
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Cells were spun down at 8 K for 10 min at 4°C, the supernatant was discarded, and the
pellet was drained and placed on ice. The pellet was then resuspended in 1/20111 volume
of 1 x P B S with 1 m M P M S F and protease inhibitor cocktail, sonicated, and 2 0 % Triton
X-100 was added to give afinalconcentration of 1 % Triton X-100. The samples were
mixed gently for 30 min, centrifuged for 10 min at 10K in 4°C, and the supernatant
containing the protein was transferred to a new tube. To purify the GST-fusion protein, 2
ml 5 0 % glutathione bead slurry (prepared by spinning down beads, washing with P B S
three times and resuspending beads in an equal volume of P B S ) was added to each 100
ml of bacterial sonicate and incubated on nutator for 30 min at room temperature. The
beads were then sedimented and washed with P B S three times.
G S T pulldowns were performed at 4°C with 10 ug of G S T fusion protein which
was added to 1 ml of B C x buffer (20 m M Tris-HCl p H 8.0, 2 0 % glycerol, x m M K C I
where x depends on require salt (i.e. B C 1 5 0 implies 150 m M KCI), 0.1 m M E D T A p H
8.0, 0.1% NP-40, 1 m M P M S F , 1 m M D T T and protease inhibitors and given quantities
of baculovirus-derived proteins. After 6 hr nutation in cold room, cells were spun down
and pellets where washed with B C buffer (usually BC300 or BC400) three times. Pellets
were resuspended in 2 x Laemelli buffer, boiled for 10 min, and then stored at -20°C until
used for immunoblotting.

Electromobility shift assays

Electromobility shift assays (EMSA) were performed using a radiolabeled
p T H 1 2 probe containing human telomeric T T A G G G repeats. The 142 bp Hindlll /
Asp718 fragment was isolated from p T H 1 2 [TTAGGG],2 and gel purified using the
QIAEXII gel purification kit. The isolated fragment was then diluted to a concentration
of 75 ng/iul. In order to label this fragment, the following mix was made: 2 ul lOx O L B
(0.5M Tris-HCl p H 6.8, 0.1 M M g O A c , 1 m M D T T , 0.5 mg/ml B S A ; aliquots stored at
-80°C) with fresh dG, dA, and d T (for 100 ul working buffer, add 0.6 ul each d G T P ,
d A T P , and d T T P (Pharmacia)), 2 ul 75 ng/ul 142 bp p T H 1 2 fragment, 5 ul 32P-a-dCTP
(3000 Ci/mmol), 10 ul H 2 0 , and 1 ul Klenow (2 U/ul). This mix is then incubated for 1
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hr at R T , add 80 ul T E N S (Tris-HCl p H 7.5, 10 m M E D T A p H 8.0, 100 m M NaCl, 0.1%
S D S ) and mix, add 5 ul sheared E. coli D N A and mix. This was purified over a Sepadex
G 5 0 column as follows: G 5 0 column equilibrated in a 3 ml syringe with T E N S , probe is
added and allowed to settle, 1 ml T E N S is added and collected, 0.8 ml T E N S is added
and collected to be used as probe. The 0.8 ml is divided into two eppendorf tubes,
extracted once with phenol/CIAA and once with chloroform. 40 phenol/CIAA 2

M

N a O A c p H 5.5 and 2 X volumes ethanol are then added to precipitate probe. The probe
is then mixed and incubated at -20 C for at least one hour, centrifuged 14K for 15 min at
4°C, washed once with 7 0 % ethanol, spun again and resuspended in 10 m M Tris-HCl p H
7.5.
For E M S A under T R F 2 conditions, samples are run on a 0.8% agarose gel made
with 0.1 x T B E . The following mix is then made: 1 ul 8 0 % glycerol, 0.5 ul 1 ug/ul
sheared E. coli D N A , 2 ul 150 m M TRIS-HC1 p H 7.5, 0.5 ul 100 ng/ul beta-casein, and
0.5 ul labeled p T H 1 2 probe. This mix is combined with the appropriate amounts of H 2 0
and quantities of protein in a total reaction volume of 20 ul. The samples are mixed
gently and incubated at room temperature for 20 minutes and then subjected to gel
electrophoresis at 200V for 30 minutes. The gel is then dried onto DE81/Whatmann
paper at 80°C on a gel dryer and exposed to phosphorimager cassette overnight.

Calcium phosphate transfection of 293T cells

Twenty-four hours before transfection, plate 4-5x106 cells per 10 cm2 plate so
that cells are 30-40% confluent at the time of transfection. 15-20 micrograms of D N A is
transfected per plate. First, the following mix for two plates if prepared (in this order):
856 ul H20, 124 ul 2 M CaCl2, 20 1 ug/ul D N A and vortex this mix. Then, 1 ml of 2 x
H B S S (50 m M H E P E S p H 7.05, 10 m M KCI, 12 m M dextrose, 280 m M NaCl, 1.5 m M
Na2P04) is added dropwise while bubbling the mix with a 1 ml pipette. 1 ml of the final
mix is added slowly and evenly onto a plate of the appropriate cells. 12-16 hr later, the
media is aspirated and 10 ml fresh media is added to the plates. Cells are typically
harvested 24 hr later.
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Co-immunoprecipitation in 293T cells

To perform co-immunoprecipitation from 293T cells, transfected 293T cells are
harvested by flushing the cells off with ice-cold P B S and the cells are transferred to a
Falcon tube. The cells are collected and the P B S is aspirated. The cells are then lysed by
resuspending them in 0.5 ml lysis buffer (50 m M Tris-HCl p H 7.4, 1 % Triton X-100,
0.1% S D S , 150 m M NaCl, 1 m M E D T A , 1 m M D T T , 1 m M P M S F , 1 ug/ul aprotinin, 10
ug/ul pepstatin, 1 ug/ul leupeptin) and gently resuspending the cells with a pippet. The
lysate is then transferred to an Eppendorf tube, vortexed 3-5 sec and kept on ice. 25 ul 5
M

NaCl (raising the sodium concentration to 400 m M ) is added to each tube. The

samples are then vortexed, incubated on ice for 5 minutes, 0.5 ml ice-old H 2 0 (sodium
concentration is now 200 m M ) is added. The samples are then mixed well after adding
H 2 0 and samples are centrifuged 14K for 10 min at 4°C. The resulting supernatant is
then transferred to a new tube and a aliquot is saved fot the input sample.
T o begin the immunoprecipitation from these prepare lysates, antibody is added
to the remaining supernatant and the samples are nutated in cold room for 5 hr. Then, 60
ul 5 0 % slurry pre-blocked protein A or protein G beads is added to each tube and the
samples are nutated in the cold room for another hour. In order to block protein A/G
beads, 3-4 ml of beads are placed into a Falcon tube, spun down down 1 K for 1 min at
4°C, and washed with P B S twice. The beads are resuspended in 10 ml of 5 % B S A in
P B S and keep on ice for 30 minutes, washed three times with P B S and stored with an
equal volume of P B S containing 0.02% sodium azide at 4°C. Then, the tubes are
centrifuged 4 K for 5 sec at 4°C to collect the beads which are then washed three or four
times with 1 ml cold lysis buffer. Thefinalcentrifugation is performed at 14K for 10 sec
at 4°C. The buffer is removed and 45-60 ul pre-boiled 2 x Laemelli buffer is added to
each pellet. The pellets are resuspend, boiled for 10 min and stored at -20°C.

Multiple Tissue Northern Blots

180

Multiple tissue northern blots (Clontech) were pre-hybridized in Church's buffer
(0.5M NaP04 p H 7.2, 1 m M E D T A p H 8.0, 7 % (w/v) S D S , 1 % (w/v) B S A ) at 55°C for 1
hr. A radiolabeled probe was then denatured at 95°C for 5 min. The blots were
hybridized in Church's buffer at overnight at 55°C and washed with Church's wash (40
m M NaP04 p H 7.2, 1 m M E D T A p H 8.0, 1 % (w/v) S D S ) and exposed to a
phosphorimager overnight.

In vitro transcription / translation

The in vitro transciption / translation system (Promega TNT coupled reticulocyte
system) is performed using RNase-free reagents. The following reagents are combined:
12.5 ul reticulocyte lysate, 1 ul T N T buffer, 0.5 ul polymerase (T7 or T3), 0.5 ul amino
acids - methionine, 2 ul S35-labeled methionine, 0.5 ul RNasin, 5.5 ul HzO, 2.5 ul of 0.2
ug /ul D N A . The mix is then incubated for 1 hr. Samples are immediately processed by
laoding 3 \i\ undiluted sample with 2 x Laemelli buffer on SDS-PAGE. One must make
sure that the dye front is off of the gel to prevent background. The gel is then incubated
with Amplify (Amersham) for 15 min, transferred to Whatmann paper, dried on a gel
dryer at 80°C for 30 min, and exposed to film.

Transient transfection by electroporation

Exponentially growing cells are harvested by trypsinization, washed once with
media, washed once with P B S and resuspended at a density of 1 xlO6 cells per ul of
transfection buffer (21 m M H E P E S p H 7.05, 137 m M NaCl, 0.7 m M Na2HP04, 5 m M
KCI, 6 m M glucose). 800 ul of suspension is then combined with 15 ug of plasmid D N A
in an electroporation cuvette and electroporated at 300 m V with a capacitance setting of
960 uF. The cell debris at the top of the cuvette was removed with a pipette tip and cells
are then plated. One-third of the volume is plated onto a 10 cm2 dish with additional
media and coverslips for immunofluorescence and two-thirds of the volume was plated
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on a 10 cm2 dish with media for protein extracts. Cells were processed 24 hr after
electroporation.

Immunofluorescence

To stain cells for immunofluorescence, tissue culture cells plated on dished with
coverslips are washed twice with PBS,fixedwith 2 % paraformaldehyde in P B S (stored at
-20°C) for 10 min at room temperature, washed twice with P B S and permeabilized with
0.5% NP-40 in P B S for 10 min at room temperature and washed three times with PBS.
Cells can be stored at 4°C wrapped in P B S with sodium azide. Coverslips are placed on
parafilm in a humidified tray and blocked with P B G (0.2% (w/v) cold waterfishgelatin
(Sigma), 0.5% (w/v) B S A (Sigma) in PBS; stored at -20°C) for 30 minutes at room
temperature. Cells are then incubated with primary antibody diluted in P B G for 3 hr at
room temperature, washed three times with P B G for 5 minutes at room temperature,
incubated with secondary antibody diluted 1:100 in P B G for 40 min at room temperature,
washed three times with P B G for 5 minutes at room temperature (with the last wash
containing 4,6-diamidino-2-phenylindole (DAPI)). Coverslips are then washed twice
with P B S and mounted on glass slides. This is done by draining the excess P B S and
placing coverslip with cells down onto a drop of embedding media (dissolve 20 m g pphenylene diamine (Sigma) in 2 ml lOx P B S by vortexing and immediately add 10 ml
glycerol, mixing carefully to avoid air bubbles and store in 1 ml aliquots at -70°C; should
be colorless and not used if yellow or brown). The excess is removed with a tissue and
the coverslip is sealed with clear nail polish.
Alternatively, cells can be pre-extracted with Triton X-100 or treated with a
cytoskeleton pre-extraction protocol. For Triton X-100 extraction, cells grown on
coverslips are rinsed twice with P B S and extracted with Triton X-100 extraction buffer
(0.5% Triton X-100, 20 m M H E P E S - K O H p H 7.9, 50 m M NaCl, 3 m M MgCl2, and 300
m M sucrose) at either room temperature or 4°C for 1-5 min. Cells are thenrinsedtwice
with P B S andfixedin 3 % paraformaldehyde/ 2 % sucrose for 10 min at room
temperature, washed twice with PBS, permeabilized in Triton X-100 buffer for 10
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minutes at room temperature,rinsedtwice with P B S and stored in P B S with sodium
azide.
Images were captured using an Axioplan2 Zeis microscope with a Hamamatsu
digital camera using OpenLab software and images were processed using Adobe
Photoshop and Adobe Illustrator.

RNAi

The following sequences were used as Rifl siRNAs:

#1, AACAGCAAGAAAUAGCACCUAdTdT; #2,
AAUGAGACUUACGUGUUAAAAdTdT; #3,
AAGAGAAACCAGGUUCUGAAGdTdT; #4,
AAGAAUGAGCCCCUAGGGAAAdTdT; #5,
AAGAGGAAAAGUCUACUGACUdTdT; #6,
AAGAGCAUCUCAGGGUUUGCUdTdT; #7,
AAGAGAGAACCAAAACUGGUAdTdT; #8,
AAGAUGAAAUCUCAUCACCUGdTdT.
53BP1 siRNAs 1 and 2 (Wang et al. 2002); A T R I P siRNAs 1 and 2 (Cortez et al.
2001); B R C A 1 (Ganesan et al. 2002); G F P (Novina et al. 2002); lamin A/C and
luciferase G L 2 (Elbashir et al. 2001); and scrambled (Dharmacon, Scramble I duplex)
were used. All siRNAs were obtained from Dharmacon. HeLa2 or U 2 0 S cells were
transfected using OligofectamineTM (Invitrogen) according to the manufacturer's
instructions. Briefly, 2.0 x IO5 of HeLa2 or 1.0 x 105 of U 2 0 S cells per well of a 6-well
plate were plated 18-24 hr prior to transfection. Transfections were done twice with a 24
hr interval. Cells were processed 48-72 hr after the first transfection as indicated. A s a
control, cells were mock treated or treated with lamin, GFP, scrambled, or luciferase
siRNAs.

Clonogenic survival assay
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Cells transfected with Rifl and control siRNAs were harvested and counted in
parallel 72 hr after transfection. The cells diluted to the same cell density (5 x IO4
cells/ml), irradiated, and subsequently plated in triplicate at a range of cell densities.
After 10 to 14 days, plates were gently washed with P B S and stained with 5 0 %
M e O H / 7 % glacial acetic acid/43% H 2 O / 0 . 1 % Coomassie Brilliant Blue G for 10 min,
rinsed with water and air-dried. Colonies were counted for the various treatments on
plates with similar numbers of colonies.
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